BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 50660931 N[C@@]1(CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1ccccc1 |r,wD:4.7,1.0,(13.25,1.68,;14.34,.58,;14.34,2.12,;15.67,2.9,;17,2.12,;17,.58,;15.67,-.18,;18.34,2.88,;19.83,2.48,;20.23,3.97,;18.74,4.37,;21.56,4.73,;22.9,3.96,;22.89,2.42,;24.23,4.73,;25.56,3.95,;26.9,4.72,;26.9,6.26,;28.23,3.94,;28.22,2.41,;29.55,1.64,;30.88,2.4,;30.88,3.95,;29.55,4.72,;32.22,4.72,;33.55,3.95,;32.22,6.26,;33.55,5.5,;13.01,-.19,;13.01,-1.72,;11.69,-2.49,;10.35,-1.73,;10.34,-.18,;11.68,.58,)| InChI=1S/C25H29F3N4O2/c26-25(27,28)19-8-4-5-17(13-19)23(34)30-14-22(33)31-20-15-32(16-20)21-9-11-24(29,12-10-21)18-6-2-1-3-7-18/h1-8,13,20-21H,9-12,14-16,29H2,(H,30,34)(H,31,33) CUVUMQNQHNMFND-UHFFFAOYSA-N 50353189 CHEMBL1829637 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 6200 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353189 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353189&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 49763575 136359875 CHEMBL1829637 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660932 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@@](F)(CC1)c1ccccc1 |r,wD:21.22,24.26,(13.62,4.95,;12.29,5.72,;12.29,7.26,;13.62,6.49,;10.96,4.95,;10.96,3.4,;9.62,2.63,;8.29,3.4,;8.3,4.94,;9.63,5.71,;6.97,5.71,;6.98,7.25,;5.64,4.95,;4.31,5.72,;2.97,4.96,;2.96,3.42,;1.64,5.73,;.3,4.96,;-.1,3.48,;-1.59,3.88,;-1.18,5.37,;-2.93,3.12,;-4.26,3.9,;-5.58,3.12,;-5.58,1.58,;-6.68,2.68,;-4.26,.82,;-2.93,1.58,;-6.92,.81,;-6.91,-.72,;-8.24,-1.5,;-9.58,-.73,;-9.59,.82,;-8.25,1.58,)| InChI=1S/C25H27F4N3O2/c26-24(18-6-2-1-3-7-18)11-9-21(10-12-24)32-15-20(16-32)31-22(33)14-30-23(34)17-5-4-8-19(13-17)25(27,28)29/h1-8,13,20-21H,9-12,14-16H2,(H,30,34)(H,31,33) UIXXHYJYOADLPS-UHFFFAOYSA-N 50353190 CHEMBL1829636 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 3300 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353190 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353190&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 49763574 136359876 CHEMBL1829636 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660933 Cc1cccc(C)c1[C@@]1(O)CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wD:12.16,8.9,(45.46,-49.44,;44.13,-48.67,;42.8,-49.45,;41.46,-48.68,;41.45,-47.13,;42.79,-46.37,;42.79,-44.83,;44.12,-47.14,;45.45,-46.37,;45.45,-47.91,;45.45,-44.83,;46.78,-44.05,;48.11,-44.83,;48.11,-46.37,;46.78,-47.13,;49.45,-44.07,;50.94,-44.47,;51.34,-42.99,;49.85,-42.58,;52.68,-42.22,;54.01,-42.99,;54,-44.53,;55.34,-42.23,;56.67,-43,;58.01,-42.24,;58.01,-40.7,;59.34,-43.01,;59.33,-44.55,;60.66,-45.32,;61.99,-44.55,;61.99,-43,;60.66,-42.24,;63.33,-42.23,;64.66,-43,;63.33,-40.69,;64.66,-41.46,)| InChI=1S/C27H32F3N3O3/c1-17-5-3-6-18(2)24(17)26(36)11-9-22(10-12-26)33-15-21(16-33)32-23(34)14-31-25(35)19-7-4-8-20(13-19)27(28,29)30/h3-8,13,21-22,36H,9-12,14-16H2,1-2H3,(H,31,35)(H,32,34) TZKCRWKVXTVJNJ-UHFFFAOYSA-N 50353191 CHEMBL1829635 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 7600 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353191 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353191&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56677289 136359877 CHEMBL1829635 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660934 O[C@@]1(CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1ccc2OCOc2c1 |r,wD:4.7,1.0,(20.7,-42.67,;21.79,-43.77,;21.79,-42.23,;23.12,-41.45,;24.45,-42.23,;24.45,-43.77,;23.12,-44.53,;25.79,-41.47,;27.28,-41.87,;27.68,-40.38,;26.19,-39.98,;29.02,-39.62,;30.35,-40.39,;30.34,-41.93,;31.68,-39.62,;33.01,-40.4,;34.35,-39.63,;34.35,-38.09,;35.68,-40.41,;35.67,-41.94,;37,-42.71,;38.33,-41.95,;38.33,-40.4,;37,-39.63,;39.67,-39.63,;41,-40.4,;39.67,-38.09,;41,-38.85,;20.46,-44.54,;19.13,-43.76,;17.79,-44.53,;17.8,-46.08,;16.66,-47.12,;17.29,-48.52,;18.83,-48.35,;19.14,-46.84,;20.47,-46.07,)| InChI=1S/C26H28F3N3O5/c27-26(28,29)18-3-1-2-16(10-18)24(34)30-12-23(33)31-19-13-32(14-19)20-6-8-25(35,9-7-20)17-4-5-21-22(11-17)37-15-36-21/h1-5,10-11,19-20,35H,6-9,12-15H2,(H,30,34)(H,31,33) JGTRPNAQMCJPRH-UHFFFAOYSA-N 50353192 CHEMBL1829633 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 13500 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353192 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353192&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 49764196 136359878 CHEMBL1829633 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660935 COc1ccc(cc1)[C@@]1(O)CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wD:12.16,8.9,(-11.77,-46.08,;-10.44,-46.85,;-9.11,-46.07,;-7.76,-46.84,;-6.44,-46.06,;-6.44,-44.53,;-7.78,-43.76,;-9.11,-44.52,;-5.11,-43.76,;-6.21,-42.66,;-5.11,-42.22,;-3.78,-41.44,;-2.45,-42.22,;-2.45,-43.76,;-3.78,-44.52,;-1.11,-41.46,;.37,-41.86,;.78,-40.37,;-.71,-39.97,;2.11,-39.61,;3.44,-40.38,;3.44,-41.92,;4.78,-39.62,;6.11,-40.39,;7.45,-39.62,;7.45,-38.08,;8.78,-40.4,;8.76,-41.93,;10.09,-42.71,;11.43,-41.94,;11.43,-40.39,;10.1,-39.62,;12.76,-39.62,;14.1,-40.39,;12.76,-38.08,;14.09,-38.84,)| InChI=1S/C26H30F3N3O4/c1-36-22-7-5-18(6-8-22)25(35)11-9-21(10-12-25)32-15-20(16-32)31-23(33)14-30-24(34)17-3-2-4-19(13-17)26(27,28)29/h2-8,13,20-21,35H,9-12,14-16H2,1H3,(H,30,34)(H,31,33) UARNPVFEWLAVGQ-UHFFFAOYSA-N 50353193 CHEMBL1829632 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 8900 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353193&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 49764322 136359879 CHEMBL1829632 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660936 CN(C)c1cccc(c1)[C@@]1(O)CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wD:13.17,9.10,(15.2,-40.76,;16.53,-39.98,;17.86,-40.75,;16.52,-38.44,;15.18,-37.68,;15.17,-36.13,;16.51,-35.36,;17.84,-36.14,;17.84,-37.67,;19.17,-35.37,;18.08,-34.27,;19.17,-33.83,;20.5,-33.05,;21.83,-33.83,;21.83,-35.37,;20.5,-36.13,;23.17,-33.07,;24.66,-33.47,;25.06,-31.98,;23.57,-31.58,;26.39,-31.22,;27.73,-31.99,;27.72,-33.53,;29.06,-31.22,;30.39,-32,;31.73,-31.23,;31.73,-29.69,;33.06,-32.01,;33.05,-33.54,;34.38,-34.31,;35.71,-33.55,;35.71,-32,;34.38,-31.23,;37.05,-31.23,;38.38,-32,;37.05,-29.69,;38.38,-30.45,)| InChI=1S/C27H33F3N4O3/c1-33(2)23-8-4-6-19(14-23)26(37)11-9-22(10-12-26)34-16-21(17-34)32-24(35)15-31-25(36)18-5-3-7-20(13-18)27(28,29)30/h3-8,13-14,21-22,37H,9-12,15-17H2,1-2H3,(H,31,36)(H,32,35) DUXDQMNXPCZQLV-UHFFFAOYSA-N 50353194 CHEMBL1829631 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 25000 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353194 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353194&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 49764446 136359880 CHEMBL1829631 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660937 O[C@@]1(CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1cccc(c1)C#N |r,wD:4.7,1.0,(-7.84,-34.16,;-6.74,-35.26,;-6.74,-33.72,;-5.41,-32.94,;-4.09,-33.72,;-4.09,-35.26,;-5.41,-36.02,;-2.75,-32.96,;-1.26,-33.36,;-.86,-31.87,;-2.34,-31.47,;.48,-31.11,;1.81,-31.88,;1.81,-33.42,;3.15,-31.11,;4.48,-31.89,;5.81,-31.12,;5.82,-29.58,;7.15,-31.9,;7.13,-33.43,;8.46,-34.2,;9.8,-33.44,;9.8,-31.89,;8.47,-31.12,;11.13,-31.12,;12.46,-31.89,;11.13,-29.58,;12.46,-30.34,;-8.08,-36.03,;-9.41,-35.26,;-10.75,-36.02,;-10.74,-37.57,;-9.4,-38.33,;-8.07,-37.56,;-9.38,-39.88,;-9.38,-41.42,)| InChI=1S/C26H27F3N4O3/c27-26(28,29)20-6-2-4-18(12-20)24(35)31-14-23(34)32-21-15-33(16-21)22-7-9-25(36,10-8-22)19-5-1-3-17(11-19)13-30/h1-6,11-12,21-22,36H,7-10,14-16H2,(H,31,35)(H,32,34) LYTSOOZQXOHDBG-UHFFFAOYSA-N 50353195 CHEMBL1829630 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 1500 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353195 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353195&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 49764701 136359881 CHEMBL1829630 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660938 O[C@@]1(CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1ccc(F)cc1 |r,wD:4.7,1.0,(18.18,-24.52,;19.27,-25.62,;19.27,-24.08,;20.6,-23.3,;21.93,-24.08,;21.93,-25.62,;20.6,-26.38,;23.27,-23.32,;24.76,-23.72,;25.16,-22.24,;23.67,-21.83,;26.5,-21.47,;27.83,-22.24,;27.82,-23.78,;29.16,-21.48,;30.49,-22.25,;31.83,-21.49,;31.83,-19.95,;33.16,-22.26,;33.15,-23.79,;34.48,-24.57,;35.81,-23.8,;35.81,-22.25,;34.48,-21.49,;37.15,-21.48,;38.48,-22.25,;37.15,-19.94,;38.48,-20.7,;17.94,-26.39,;17.95,-27.92,;16.62,-28.7,;15.28,-27.93,;13.95,-28.71,;15.27,-26.38,;16.61,-25.62,)| InChI=1S/C25H27F4N3O3/c26-19-6-4-17(5-7-19)24(35)10-8-21(9-11-24)32-14-20(15-32)31-22(33)13-30-23(34)16-2-1-3-18(12-16)25(27,28)29/h1-7,12,20-21,35H,8-11,13-15H2,(H,30,34)(H,31,33) XULVMRUMTSIIFH-UHFFFAOYSA-N 50353196 CHEMBL1829629 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 2800 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353196 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353196&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 49764700 136359882 CHEMBL1829629 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660939 O[C@@]1(CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1ccccc1 |r,wD:4.7,1.0,(-9.36,-27.63,;-8.26,-28.72,;-8.26,-27.18,;-6.93,-26.41,;-5.6,-27.18,;-5.6,-28.72,;-6.93,-29.49,;-4.26,-26.42,;-2.78,-26.83,;-2.37,-25.34,;-3.86,-24.94,;-1.04,-24.57,;.29,-25.35,;.29,-26.89,;1.63,-24.58,;2.96,-25.35,;4.3,-24.59,;4.3,-23.05,;5.63,-25.36,;5.61,-26.9,;6.94,-27.67,;8.28,-26.91,;8.28,-25.36,;6.95,-24.59,;9.61,-24.59,;10.95,-25.36,;9.61,-23.05,;10.94,-23.81,;-9.59,-29.49,;-9.59,-31.03,;-10.91,-31.8,;-12.26,-31.03,;-12.27,-29.48,;-10.93,-28.72,)| InChI=1S/C25H28F3N3O3/c26-25(27,28)19-8-4-5-17(13-19)23(33)29-14-22(32)30-20-15-31(16-20)21-9-11-24(34,12-10-21)18-6-2-1-3-7-18/h1-8,13,20-21,34H,9-12,14-16H2,(H,29,33)(H,30,32) QCPLMEBVJKAVGY-UHFFFAOYSA-N 50353197 CHEMBL1829628 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 10000 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353197 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353197&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 46927116 136359883 CHEMBL1829628 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660940 O[C@@]1(CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1cccnc1 |r,wD:4.7,1.0,(18.02,-17.13,;19.12,-18.23,;19.12,-16.69,;20.45,-15.91,;21.78,-16.69,;21.78,-18.23,;20.45,-18.99,;23.11,-15.93,;24.6,-16.33,;25,-14.85,;23.52,-14.44,;26.34,-14.08,;27.67,-14.85,;27.67,-16.39,;29.01,-14.09,;30.34,-14.86,;31.67,-14.1,;31.68,-12.56,;33.01,-14.87,;32.99,-16.41,;34.32,-17.18,;35.66,-16.41,;35.66,-14.86,;34.33,-14.1,;36.99,-14.09,;38.33,-14.86,;36.99,-12.55,;38.32,-13.32,;17.79,-19,;16.45,-18.23,;15.11,-18.99,;15.12,-20.54,;16.46,-21.31,;17.79,-20.53,)| InChI=1S/C24H27F3N4O3/c25-24(26,27)17-4-1-3-16(11-17)22(33)29-13-21(32)30-19-14-31(15-19)20-6-8-23(34,9-7-20)18-5-2-10-28-12-18/h1-5,10-12,19-20,34H,6-9,13-15H2,(H,29,33)(H,30,32) YBQZLWPFQRLDTC-UHFFFAOYSA-N 50353198 CHEMBL1829603 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 35000 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353198 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353198&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 46241829 136359884 CHEMBL1829603 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660941 Nc1ccc(nc1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:7.7,wD:10.14,(10.98,-48.4,;12.31,-47.62,;13.65,-48.39,;14.97,-47.62,;14.97,-46.08,;13.64,-45.31,;12.3,-46.07,;16.3,-45.31,;16.3,-43.77,;17.63,-43,;18.96,-43.77,;18.96,-45.31,;17.63,-46.08,;20.3,-43.01,;21.79,-43.42,;22.19,-41.93,;20.7,-41.53,;23.52,-41.16,;24.86,-41.94,;24.85,-43.48,;26.19,-41.17,;27.52,-41.94,;28.86,-41.18,;28.86,-39.64,;30.19,-41.95,;30.18,-43.49,;31.51,-44.26,;32.84,-43.5,;32.84,-41.95,;31.51,-41.18,;34.18,-41.18,;35.51,-41.95,;34.18,-39.64,;35.51,-40.4,)| InChI=1S/C24H28F3N5O2/c25-24(26,27)17-3-1-2-16(10-17)23(34)30-12-22(33)31-19-13-32(14-19)20-7-4-15(5-8-20)21-9-6-18(28)11-29-21/h1-3,6,9-11,15,19-20H,4-5,7-8,12-14,28H2,(H,30,34)(H,31,33) UOPRHVPDLPNSEU-UHFFFAOYSA-N 50353199 CHEMBL1829627 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 37000 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353199 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353199&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 46945255 136359885 CHEMBL1829627 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660942 Nc1cccnc1[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:7.7,wD:10.14,(-5.78,-48.09,;-7.11,-47.33,;-8.44,-48.1,;-9.78,-47.34,;-9.79,-45.79,;-8.45,-45.02,;-7.12,-45.8,;-5.79,-45.03,;-5.79,-43.49,;-4.46,-42.71,;-3.13,-43.49,;-3.13,-45.03,;-4.46,-45.79,;-1.79,-42.73,;-.3,-43.13,;.1,-41.64,;-1.39,-41.24,;1.44,-40.88,;2.77,-41.65,;2.76,-43.19,;4.1,-40.88,;5.43,-41.66,;6.77,-40.89,;6.77,-39.35,;8.1,-41.67,;8.09,-43.2,;9.42,-43.97,;10.75,-43.21,;10.75,-41.66,;9.42,-40.89,;12.09,-40.89,;13.42,-41.66,;12.09,-39.35,;13.42,-40.11,)| InChI=1S/C24H28F3N5O2/c25-24(26,27)17-4-1-3-16(11-17)23(34)30-12-21(33)31-18-13-32(14-18)19-8-6-15(7-9-19)22-20(28)5-2-10-29-22/h1-5,10-11,15,18-19H,6-9,12-14,28H2,(H,30,34)(H,31,33) WTXGXHROIBXUJC-UHFFFAOYSA-N 50353200 CHEMBL1829626 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 44000 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353200&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 46945254 136359886 CHEMBL1829626 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660943 Oc1cnccc1[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:7.7,wD:10.14,(16.43,-33.33,;16.42,-34.87,;15.08,-35.63,;15.09,-37.18,;16.43,-37.95,;17.76,-37.17,;17.75,-35.64,;19.09,-34.87,;19.09,-33.33,;20.42,-32.55,;21.74,-33.33,;21.74,-34.87,;20.42,-35.63,;23.08,-32.57,;24.57,-32.97,;24.97,-31.48,;23.49,-31.08,;26.31,-30.72,;27.64,-31.49,;27.64,-33.03,;28.98,-30.73,;30.31,-31.5,;31.64,-30.73,;31.65,-29.19,;32.98,-31.51,;32.96,-33.04,;34.29,-33.82,;35.63,-33.05,;35.63,-31.5,;34.3,-30.73,;36.96,-30.73,;38.29,-31.5,;36.96,-29.19,;38.29,-29.95,)| InChI=1S/C24H27F3N4O3/c25-24(26,27)17-3-1-2-16(10-17)23(34)29-12-22(33)30-18-13-31(14-18)19-6-4-15(5-7-19)20-8-9-28-11-21(20)32/h1-3,8-11,15,18-19,32H,4-7,12-14H2,(H,29,34)(H,30,33) OWGBFYYPIAIMDH-UHFFFAOYSA-N 50353201 CHEMBL1829625 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 23000 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353201 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353201&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 46944855 136359887 CHEMBL1829625 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660944 Oc1ccc(nc1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:7.7,wD:10.14,(-11.29,-40.7,;-9.96,-39.92,;-8.62,-40.69,;-7.29,-39.92,;-7.3,-38.38,;-8.63,-37.61,;-9.97,-38.37,;-5.97,-37.61,;-5.97,-36.07,;-4.64,-35.3,;-3.31,-36.07,;-3.31,-37.61,;-4.64,-38.38,;-1.97,-35.31,;-.48,-35.72,;-.08,-34.23,;-1.57,-33.83,;1.26,-33.46,;2.59,-34.24,;2.58,-35.78,;3.92,-33.47,;5.26,-34.24,;6.59,-33.48,;6.6,-31.94,;7.92,-34.25,;7.91,-35.79,;9.24,-36.56,;10.58,-35.8,;10.58,-34.25,;9.24,-33.48,;11.91,-33.48,;13.24,-34.25,;11.91,-31.94,;13.24,-32.7,)| InChI=1S/C24H27F3N4O3/c25-24(26,27)17-3-1-2-16(10-17)23(34)29-12-22(33)30-18-13-31(14-18)19-6-4-15(5-7-19)21-9-8-20(32)11-28-21/h1-3,8-11,15,18-19,32H,4-7,12-14H2,(H,29,34)(H,30,33) ZXLRVOHADIRDTA-UHFFFAOYSA-N 50353202 CHEMBL1829624 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 10000 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353202 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353202&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 46947816 136359888 CHEMBL1829624 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660945 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@@H](CC1)c1cnccn1 |r,wU:24.29,wD:21.22,(12.97,-24.1,;11.64,-23.33,;11.64,-21.79,;12.97,-22.56,;10.3,-24.1,;10.3,-25.65,;8.97,-26.42,;7.64,-25.65,;7.65,-24.11,;8.97,-23.34,;6.32,-23.34,;6.32,-21.8,;4.98,-24.1,;3.65,-23.33,;2.32,-24.09,;2.31,-25.63,;.98,-23.32,;-.35,-24.09,;-.75,-25.57,;-2.24,-25.17,;-1.84,-23.68,;-3.58,-25.93,;-4.91,-25.15,;-6.24,-25.93,;-6.24,-27.47,;-4.91,-28.23,;-3.58,-27.47,;-7.57,-28.24,;-7.57,-29.77,;-8.89,-30.55,;-10.23,-29.78,;-10.24,-28.23,;-8.9,-27.47,)| InChI=1S/C23H26F3N5O2/c24-23(25,26)17-3-1-2-16(10-17)22(33)29-12-21(32)30-18-13-31(14-18)19-6-4-15(5-7-19)20-11-27-8-9-28-20/h1-3,8-11,15,18-19H,4-7,12-14H2,(H,29,33)(H,30,32) YCFZQCRYKACGKE-UHFFFAOYSA-N 50353203 CHEMBL1829622 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 12000 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353203 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353203&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 46945857 136359889 CHEMBL1829622 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660946 COc1cnccc1[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:8.8,wD:11.15,(-6.76,-16.65,;-8.1,-17.41,;-8.1,-18.95,;-9.44,-19.72,;-9.43,-21.27,;-8.09,-22.03,;-6.76,-21.26,;-6.77,-19.73,;-5.44,-18.95,;-5.44,-17.41,;-4.11,-16.64,;-2.78,-17.41,;-2.78,-18.95,;-4.11,-19.72,;-1.44,-16.65,;.05,-17.06,;.45,-15.57,;-1.04,-15.17,;1.79,-14.8,;3.12,-15.58,;3.11,-17.12,;4.45,-14.81,;5.78,-15.59,;7.12,-14.82,;7.12,-13.28,;8.45,-15.59,;8.44,-17.13,;9.77,-17.9,;11.1,-17.14,;11.1,-15.59,;9.77,-14.82,;12.44,-14.82,;13.77,-15.59,;12.44,-13.28,;13.77,-14.04,)| InChI=1S/C25H29F3N4O3/c1-35-22-12-29-10-9-21(22)16-5-7-20(8-6-16)32-14-19(15-32)31-23(33)13-30-24(34)17-3-2-4-18(11-17)25(26,27)28/h2-4,9-12,16,19-20H,5-8,13-15H2,1H3,(H,30,34)(H,31,33) JBYSLYJGZMRBFN-UHFFFAOYSA-N 50353204 CHEMBL1829620 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 8200 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353204 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353204&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 46944854 136359890 CHEMBL1829620 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660947 COc1ccc(cn1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:8.8,wD:11.15,(10.22,-11.72,;11.56,-12.48,;12.89,-11.71,;12.88,-10.16,;14.22,-9.39,;15.55,-10.17,;15.56,-11.7,;14.23,-12.47,;16.89,-9.4,;16.89,-7.86,;18.21,-7.08,;19.54,-7.86,;19.54,-9.4,;18.21,-10.16,;20.88,-7.1,;22.37,-7.5,;22.77,-6.01,;21.29,-5.61,;24.11,-5.25,;25.44,-6.02,;25.43,-7.56,;26.78,-5.25,;28.11,-6.03,;29.44,-5.26,;29.45,-3.72,;30.77,-6.04,;30.76,-7.57,;32.09,-8.34,;33.43,-7.58,;33.43,-6.03,;32.1,-5.26,;34.76,-5.26,;36.09,-6.03,;34.76,-3.72,;36.09,-4.48,)| InChI=1S/C25H29F3N4O3/c1-35-23-10-7-18(12-29-23)16-5-8-21(9-6-16)32-14-20(15-32)31-22(33)13-30-24(34)17-3-2-4-19(11-17)25(26,27)28/h2-4,7,10-12,16,20-21H,5-6,8-9,13-15H2,1H3,(H,30,34)(H,31,33) PWZJJDJNMPHXPO-UHFFFAOYSA-N 50353205 CHEMBL1829619 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 2800 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353205 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353205&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 46927117 136359891 CHEMBL1829619 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660948 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@@H](CC1)c1cccnc1 |r,wU:24.29,wD:21.22,(14.18,-6.67,;12.85,-5.9,;12.85,-4.36,;14.18,-5.13,;11.52,-6.67,;11.52,-8.22,;10.18,-8.99,;8.85,-8.22,;8.86,-6.68,;10.19,-5.91,;7.53,-5.91,;7.54,-4.37,;6.2,-6.67,;4.87,-5.9,;3.53,-6.66,;3.52,-8.2,;2.2,-5.89,;.86,-6.66,;.46,-8.14,;-1.03,-7.74,;-.62,-6.25,;-2.37,-8.5,;-3.7,-7.72,;-5.02,-8.5,;-5.02,-10.04,;-3.7,-10.8,;-2.37,-10.04,;-6.36,-10.81,;-7.69,-10.04,;-9.03,-10.8,;-9.02,-12.35,;-7.68,-13.12,;-6.35,-12.34,)| InChI=1S/C24H27F3N4O2/c25-24(26,27)19-5-1-3-17(11-19)23(33)29-13-22(32)30-20-14-31(15-20)21-8-6-16(7-9-21)18-4-2-10-28-12-18/h1-5,10-12,16,20-21H,6-9,13-15H2,(H,29,33)(H,30,32) BAZCORFCZVDJNX-UHFFFAOYSA-N 50353206 CHEMBL1829618 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 3800 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353206 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353206&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56667036 136359892 CHEMBL1829618 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660949 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@@H](CC1)c1ccc2nc[nH]c2c1 |r,wU:24.29,wD:21.22,(37.55,4.46,;36.21,5.23,;36.21,6.77,;37.54,6,;34.88,4.46,;34.88,2.91,;33.54,2.14,;32.21,2.91,;32.23,4.45,;33.55,5.22,;30.9,5.22,;30.9,6.76,;29.56,4.46,;28.23,5.23,;26.89,4.47,;26.89,2.93,;25.56,5.24,;24.23,4.47,;23.82,2.99,;22.34,3.39,;22.74,4.88,;21,2.63,;19.67,3.41,;18.34,2.63,;18.34,1.09,;19.67,.33,;21,1.09,;17.01,.32,;17.01,-1.21,;15.69,-1.99,;14.34,-1.22,;12.87,-1.71,;11.95,-.46,;12.86,.8,;14.34,.33,;15.67,1.09,)| InChI=1S/C26H28F3N5O2/c27-26(28,29)19-3-1-2-18(10-19)25(36)30-12-24(35)33-20-13-34(14-20)21-7-4-16(5-8-21)17-6-9-22-23(11-17)32-15-31-22/h1-3,6,9-11,15-16,20-21H,4-5,7-8,12-14H2,(H,30,36)(H,31,32)(H,33,35) VKTHBCCPYLGDJQ-UHFFFAOYSA-N 50353207 CHEMBL1829617 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 2500 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353207 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353207&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 49763931 136359893 CHEMBL1829617 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660950 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@@H](CC1)c1ccc(cc1)N1CCCC1 |r,wU:24.29,wD:21.22,(17.01,5.96,;15.68,6.73,;15.68,8.27,;17.01,7.51,;14.35,5.96,;14.35,4.41,;13.01,3.64,;11.68,4.42,;11.7,5.95,;13.02,6.72,;10.36,6.72,;10.37,8.27,;9.03,5.96,;7.7,6.73,;6.36,5.97,;6.36,4.43,;5.03,6.74,;3.69,5.97,;3.29,4.49,;1.8,4.89,;2.21,6.38,;.46,4.13,;-.86,4.91,;-2.19,4.13,;-2.19,2.59,;-.86,1.83,;.46,2.59,;-3.53,1.82,;-4.86,2.59,;-6.2,1.83,;-6.19,.28,;-4.85,-.49,;-3.52,.29,;-7.53,-.49,;-8.93,.13,;-9.96,-1.02,;-9.18,-2.35,;-7.68,-2.02,)| InChI=1S/C29H35F3N4O2/c30-29(31,32)23-5-3-4-22(16-23)28(38)33-17-27(37)34-24-18-36(19-24)26-12-8-21(9-13-26)20-6-10-25(11-7-20)35-14-1-2-15-35/h3-7,10-11,16,21,24,26H,1-2,8-9,12-15,17-19H2,(H,33,38)(H,34,37) JZRORTLHTQXXDH-UHFFFAOYSA-N 50353208 CHEMBL1829616 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 7900 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353208 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353208&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 49763804 136359894 CHEMBL1829616 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660951 OC(=O)c1ccc(cc1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:9.9,wD:12.16,(14.46,-48.36,;15.8,-49.12,;15.8,-50.66,;17.13,-48.35,;17.12,-46.8,;18.46,-46.04,;19.79,-46.81,;19.8,-48.34,;18.47,-49.11,;21.12,-46.04,;21.12,-44.5,;22.45,-43.72,;23.78,-44.5,;23.78,-46.04,;22.45,-46.8,;25.12,-43.74,;26.61,-44.14,;27.01,-42.65,;25.52,-42.25,;28.35,-41.89,;29.68,-42.66,;29.67,-44.2,;31.01,-41.89,;32.35,-42.67,;33.68,-41.9,;33.69,-40.36,;35.01,-42.68,;35,-44.21,;36.33,-44.98,;37.67,-44.22,;37.67,-42.67,;36.33,-41.9,;39,-41.9,;40.33,-42.67,;39,-40.36,;40.33,-41.12,)| InChI=1S/C26H28F3N3O4/c27-26(28,29)20-3-1-2-19(12-20)24(34)30-13-23(33)31-21-14-32(15-21)22-10-8-17(9-11-22)16-4-6-18(7-5-16)25(35)36/h1-7,12,17,21-22H,8-11,13-15H2,(H,30,34)(H,31,33)(H,35,36) GSASYNLMWPJCFM-UHFFFAOYSA-N 50353209 CHEMBL1829615 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 23000 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353209 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353209&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 49763686 136359895 CHEMBL1829615 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660952 COC(=O)c1ccc(cc1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:10.10,wD:13.17,(-13.75,-48.63,;-13.75,-50.17,;-12.41,-50.93,;-12.4,-52.47,;-11.07,-50.16,;-11.08,-48.61,;-9.74,-47.85,;-8.41,-48.62,;-8.41,-50.15,;-9.73,-50.93,;-7.08,-47.85,;-7.08,-46.31,;-5.75,-45.53,;-4.42,-46.31,;-4.42,-47.85,;-5.75,-48.61,;-3.08,-45.55,;-1.59,-45.95,;-1.19,-44.46,;-2.68,-44.06,;.14,-43.7,;1.48,-44.47,;1.47,-46.01,;2.81,-43.71,;4.14,-44.48,;5.48,-43.71,;5.48,-42.17,;6.81,-44.49,;6.8,-46.02,;8.13,-46.8,;9.46,-46.03,;9.46,-44.48,;8.13,-43.72,;10.8,-43.71,;12.13,-44.48,;10.8,-42.17,;12.13,-42.93,)| InChI=1S/C27H30F3N3O4/c1-37-26(36)19-7-5-17(6-8-19)18-9-11-23(12-10-18)33-15-22(16-33)32-24(34)14-31-25(35)20-3-2-4-21(13-20)27(28,29)30/h2-8,13,18,22-23H,9-12,14-16H2,1H3,(H,31,35)(H,32,34) PUGUKUOQIIUORX-UHFFFAOYSA-N 50353210 CHEMBL1829614 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 1300 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353210 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353210&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 49763685 136359896 CHEMBL1829614 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660953 Oc1ccc(cc1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:7.7,wD:10.14,(12.86,-42.14,;14.19,-41.36,;15.53,-42.13,;16.86,-41.36,;16.85,-39.82,;15.52,-39.05,;14.18,-39.81,;18.18,-39.05,;18.18,-37.51,;19.51,-36.73,;20.84,-37.51,;20.84,-39.05,;19.51,-39.81,;22.18,-36.75,;23.67,-37.15,;24.07,-35.67,;22.58,-35.27,;25.41,-34.9,;26.74,-35.68,;26.73,-37.22,;28.07,-34.91,;29.41,-35.68,;30.74,-34.92,;30.75,-33.38,;32.07,-35.69,;32.06,-37.23,;33.39,-38,;34.73,-37.23,;34.73,-35.69,;33.39,-34.92,;36.06,-34.92,;37.39,-35.68,;36.06,-33.38,;37.39,-34.14,)| InChI=1S/C25H28F3N3O3/c26-25(27,28)19-3-1-2-18(12-19)24(34)29-13-23(33)30-20-14-31(15-20)21-8-4-16(5-9-21)17-6-10-22(32)11-7-17/h1-3,6-7,10-12,16,20-21,32H,4-5,8-9,13-15H2,(H,29,34)(H,30,33) VJYPOQFOBLLZGR-UHFFFAOYSA-N 50353211 CHEMBL1829613 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 4100 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353211 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353211&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 49764447 136359897 CHEMBL1829613 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660954 COc1ccc(cc1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:8.8,wD:11.15,(-11.84,-42.24,;-10.51,-43.01,;-9.18,-42.23,;-7.83,-43,;-6.51,-42.23,;-6.51,-40.69,;-7.85,-39.92,;-9.18,-40.68,;-5.18,-39.92,;-5.18,-38.38,;-3.85,-37.61,;-2.52,-38.38,;-2.52,-39.92,;-3.85,-40.69,;-1.18,-37.62,;.3,-38.03,;.71,-36.54,;-.78,-36.14,;2.04,-35.77,;3.37,-36.55,;3.37,-38.09,;4.71,-35.78,;6.04,-36.55,;7.38,-35.79,;7.38,-34.25,;8.71,-36.56,;8.69,-38.1,;10.02,-38.87,;11.36,-38.11,;11.36,-36.56,;10.03,-35.79,;12.69,-35.79,;14.03,-36.56,;12.69,-34.25,;14.02,-35.01,)| InChI=1S/C26H30F3N3O3/c1-35-23-11-7-18(8-12-23)17-5-9-22(10-6-17)32-15-21(16-32)31-24(33)14-30-25(34)19-3-2-4-20(13-19)26(27,28)29/h2-4,7-8,11-13,17,21-22H,5-6,9-10,14-16H2,1H3,(H,30,34)(H,31,33) GJYACPVUIOTYOV-UHFFFAOYSA-N 50353212 CHEMBL1829612 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 3000 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353212 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353212&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 49763682 136359898 CHEMBL1829612 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660955 FC(F)(F)c1ccc(cc1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@@H](CC1)c1ccc2OCOc2c1 |r,wU:24.29,wD:21.22,(33.58,-29.8,;33.58,-28.26,;34.92,-27.49,;34.91,-29.03,;32.25,-27.49,;30.91,-28.25,;29.58,-27.48,;29.6,-25.95,;30.92,-25.17,;32.25,-25.94,;28.27,-25.17,;28.27,-23.63,;26.93,-25.94,;25.6,-25.16,;24.26,-25.93,;24.26,-27.47,;22.93,-25.16,;21.6,-25.92,;21.19,-27.41,;19.71,-27.01,;20.11,-25.52,;18.37,-27.77,;17.04,-26.99,;15.71,-27.77,;15.71,-29.31,;17.04,-30.07,;18.37,-29.31,;14.38,-30.08,;14.38,-31.61,;13.06,-32.38,;11.71,-31.62,;10.24,-32.1,;9.33,-30.85,;10.23,-29.6,;11.71,-30.07,;13.05,-29.31,)| InChI=1S/C26H28F3N3O4/c27-26(28,29)19-6-1-17(2-7-19)25(34)30-12-24(33)31-20-13-32(14-20)21-8-3-16(4-9-21)18-5-10-22-23(11-18)36-15-35-22/h1-2,5-7,10-11,16,20-21H,3-4,8-9,12-15H2,(H,30,34)(H,31,33) ZKCFIHVGKYMOOL-UHFFFAOYSA-N 50353213 CHEMBL1829611 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 1500 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353213 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353213&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56677296 136359899 CHEMBL1829611 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660956 O=C(CNC(=O)c1ccccc1)NC1CN(C1)[C@H]1CC[C@@H](CC1)c1ccc2OCOc2c1 |r,wU:20.25,wD:17.18,(3.49,-27.07,;3.5,-25.53,;4.83,-24.77,;6.17,-25.54,;7.5,-24.78,;7.51,-23.24,;8.83,-25.55,;8.82,-27.08,;10.15,-27.86,;11.49,-27.09,;11.49,-25.54,;10.15,-24.78,;2.17,-24.76,;.83,-25.53,;.43,-27.01,;-1.06,-26.61,;-.66,-25.12,;-2.4,-27.37,;-3.73,-26.59,;-5.06,-27.37,;-5.06,-28.91,;-3.73,-29.67,;-2.4,-28.91,;-6.39,-29.68,;-6.38,-31.21,;-7.71,-31.99,;-9.05,-31.22,;-10.52,-31.71,;-11.44,-30.46,;-10.53,-29.2,;-9.06,-29.67,;-7.72,-28.91,)| InChI=1S/C25H29N3O4/c29-24(13-26-25(30)18-4-2-1-3-5-18)27-20-14-28(15-20)21-9-6-17(7-10-21)19-8-11-22-23(12-19)32-16-31-22/h1-5,8,11-12,17,20-21H,6-7,9-10,13-16H2,(H,26,30)(H,27,29) VLGQQGBAZGCDNJ-UHFFFAOYSA-N 50353214 CHEMBL1829610 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 2800 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353214 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353214&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 49763569 136359900 CHEMBL1829610 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660957 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@@H](CC1)c1ccccc1 |r,wU:24.29,wD:21.22,(36.3,-16.68,;34.96,-15.91,;34.96,-14.37,;36.29,-15.14,;33.63,-16.68,;33.63,-18.23,;32.29,-19,;30.96,-18.23,;30.98,-16.69,;32.3,-15.92,;29.64,-15.92,;29.65,-14.38,;28.31,-16.68,;26.98,-15.91,;25.64,-16.67,;25.64,-18.21,;24.31,-15.9,;22.97,-16.67,;22.57,-18.15,;21.08,-17.75,;21.49,-16.26,;19.75,-18.51,;18.42,-17.73,;17.09,-18.51,;17.09,-20.05,;18.42,-20.81,;19.75,-20.05,;15.76,-20.82,;15.76,-22.35,;14.43,-23.13,;13.09,-22.36,;13.08,-20.81,;14.42,-20.05,)| InChI=1S/C25H28F3N3O2/c26-25(27,28)20-8-4-7-19(13-20)24(33)29-14-23(32)30-21-15-31(16-21)22-11-9-18(10-12-22)17-5-2-1-3-6-17/h1-8,13,18,21-22H,9-12,14-16H2,(H,29,33)(H,30,32) NMRHWRNUJPVSFE-UHFFFAOYSA-N 50353215 CHEMBL1829609 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 4000 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353215 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353215&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 49763571 136359901 CHEMBL1829609 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660958 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@H](CC1)c1ccc2OCOc2c1 |r,wU:21.22,24.29,(36.71,2.26,;35.37,3.03,;35.37,4.57,;36.7,3.81,;34.04,2.26,;34.04,.71,;32.7,-.05,;31.37,.72,;31.39,2.26,;32.71,3.03,;30.06,3.03,;30.06,4.57,;28.72,2.26,;27.39,3.04,;26.05,2.27,;26.05,.73,;24.72,3.05,;23.39,2.28,;22.98,.79,;21.5,1.2,;21.9,2.68,;20.16,.44,;20.16,-1.1,;18.83,-1.87,;17.5,-1.1,;17.5,.44,;18.83,1.21,;16.17,-1.88,;16.17,-3.41,;14.85,-4.18,;13.5,-3.41,;12.03,-3.9,;11.12,-2.65,;12.02,-1.39,;13.5,-1.87,;14.83,-1.1,)| InChI=1S/C26H28F3N3O4/c27-26(28,29)19-3-1-2-18(10-19)25(34)30-12-24(33)31-20-13-32(14-20)21-7-4-16(5-8-21)17-6-9-22-23(11-17)36-15-35-22/h1-3,6,9-11,16,20-21H,4-5,7-8,12-15H2,(H,30,34)(H,31,33) QTNRUICBYFHOBZ-UHFFFAOYSA-N 50353216 CHEMBL1829605 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 2800 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353216 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353216&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 49763568 136359902 CHEMBL1829605 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50660959 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@@](F)(CC1)c1ccccc1 |r,wD:21.22,24.26,(13.62,4.95,;12.29,5.72,;12.29,7.26,;13.62,6.49,;10.96,4.95,;10.96,3.4,;9.62,2.63,;8.29,3.4,;8.3,4.94,;9.63,5.71,;6.97,5.71,;6.98,7.25,;5.64,4.95,;4.31,5.72,;2.97,4.96,;2.96,3.42,;1.64,5.73,;.3,4.96,;-.1,3.48,;-1.59,3.88,;-1.18,5.37,;-2.93,3.12,;-4.26,3.9,;-5.58,3.12,;-5.58,1.58,;-6.68,2.68,;-4.26,.82,;-2.93,1.58,;-6.92,.81,;-6.91,-.72,;-8.24,-1.5,;-9.58,-.73,;-9.59,.82,;-8.25,1.58,)| InChI=1S/C25H27F4N3O2/c26-24(18-6-2-1-3-7-18)11-9-21(10-12-24)32-15-20(16-32)31-22(33)14-30-23(34)17-5-4-8-19(13-17)25(27,28)29/h1-8,13,20-21H,9-12,14-16H2,(H,30,34)(H,31,33) UIXXHYJYOADLPS-UHFFFAOYSA-N 50353190 CHEMBL1829636 C-C chemokine receptor type 2 Homo sapiens 170 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353190 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353190&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49763574 136359876 CHEMBL1829636 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660960 O[C@@]1(CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1ccc2CCOc2c1 |r,wD:4.7,1.0,(45,-44.46,;46.1,-45.55,;46.1,-44.01,;47.43,-43.24,;48.76,-44.01,;48.76,-45.55,;47.43,-46.32,;50.1,-43.25,;51.58,-43.66,;51.99,-42.17,;50.5,-41.77,;53.32,-41.4,;54.65,-42.18,;54.65,-43.72,;55.99,-41.41,;57.32,-42.19,;58.66,-41.42,;58.66,-39.88,;59.99,-42.19,;59.97,-43.73,;61.3,-44.5,;62.64,-43.74,;62.64,-42.19,;61.31,-41.42,;63.97,-41.42,;65.31,-42.19,;63.97,-39.88,;65.3,-40.64,;44.77,-46.33,;43.43,-45.55,;42.09,-46.32,;42.1,-47.87,;40.96,-48.91,;41.6,-50.31,;43.13,-50.14,;43.45,-48.63,;44.77,-47.86,)| InChI=1S/C27H30F3N3O4/c28-27(29,30)20-3-1-2-18(12-20)25(35)31-14-24(34)32-21-15-33(16-21)22-6-9-26(36,10-7-22)19-5-4-17-8-11-37-23(17)13-19/h1-5,12-13,21-22,36H,6-11,14-16H2,(H,31,35)(H,32,34) MUASMHOMZSYLAM-UHFFFAOYSA-N 50353217 CHEMBL1829634 C-C chemokine receptor type 2 Homo sapiens 52 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353217&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56677288 136359903 CHEMBL1829634 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660961 O[C@@]1(CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1ccc2OCOc2c1 |r,wD:4.7,1.0,(20.7,-42.67,;21.79,-43.77,;21.79,-42.23,;23.12,-41.45,;24.45,-42.23,;24.45,-43.77,;23.12,-44.53,;25.79,-41.47,;27.28,-41.87,;27.68,-40.38,;26.19,-39.98,;29.02,-39.62,;30.35,-40.39,;30.34,-41.93,;31.68,-39.62,;33.01,-40.4,;34.35,-39.63,;34.35,-38.09,;35.68,-40.41,;35.67,-41.94,;37,-42.71,;38.33,-41.95,;38.33,-40.4,;37,-39.63,;39.67,-39.63,;41,-40.4,;39.67,-38.09,;41,-38.85,;20.46,-44.54,;19.13,-43.76,;17.79,-44.53,;17.8,-46.08,;16.66,-47.12,;17.29,-48.52,;18.83,-48.35,;19.14,-46.84,;20.47,-46.07,)| InChI=1S/C26H28F3N3O5/c27-26(28,29)18-3-1-2-16(10-18)24(34)30-12-23(33)31-19-13-32(14-19)20-6-8-25(35,9-7-20)17-4-5-21-22(11-17)37-15-36-21/h1-5,10-11,19-20,35H,6-9,12-15H2,(H,30,34)(H,31,33) JGTRPNAQMCJPRH-UHFFFAOYSA-N 50353192 CHEMBL1829633 C-C chemokine receptor type 2 Homo sapiens 27 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353192 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353192&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49764196 136359878 CHEMBL1829633 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660962 COc1ccc(cc1)[C@@]1(O)CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wD:12.16,8.9,(-11.77,-46.08,;-10.44,-46.85,;-9.11,-46.07,;-7.76,-46.84,;-6.44,-46.06,;-6.44,-44.53,;-7.78,-43.76,;-9.11,-44.52,;-5.11,-43.76,;-6.21,-42.66,;-5.11,-42.22,;-3.78,-41.44,;-2.45,-42.22,;-2.45,-43.76,;-3.78,-44.52,;-1.11,-41.46,;.37,-41.86,;.78,-40.37,;-.71,-39.97,;2.11,-39.61,;3.44,-40.38,;3.44,-41.92,;4.78,-39.62,;6.11,-40.39,;7.45,-39.62,;7.45,-38.08,;8.78,-40.4,;8.76,-41.93,;10.09,-42.71,;11.43,-41.94,;11.43,-40.39,;10.1,-39.62,;12.76,-39.62,;14.1,-40.39,;12.76,-38.08,;14.09,-38.84,)| InChI=1S/C26H30F3N3O4/c1-36-22-7-5-18(6-8-22)25(35)11-9-21(10-12-25)32-15-20(16-32)31-23(33)14-30-24(34)17-3-2-4-19(13-17)26(27,28)29/h2-8,13,20-21,35H,9-12,14-16H2,1H3,(H,30,34)(H,31,33) UARNPVFEWLAVGQ-UHFFFAOYSA-N 50353193 CHEMBL1829632 C-C chemokine receptor type 2 Homo sapiens 67 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353193&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49764322 136359879 CHEMBL1829632 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660963 CN(C)c1cccc(c1)[C@@]1(O)CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wD:13.17,9.10,(15.2,-40.76,;16.53,-39.98,;17.86,-40.75,;16.52,-38.44,;15.18,-37.68,;15.17,-36.13,;16.51,-35.36,;17.84,-36.14,;17.84,-37.67,;19.17,-35.37,;18.08,-34.27,;19.17,-33.83,;20.5,-33.05,;21.83,-33.83,;21.83,-35.37,;20.5,-36.13,;23.17,-33.07,;24.66,-33.47,;25.06,-31.98,;23.57,-31.58,;26.39,-31.22,;27.73,-31.99,;27.72,-33.53,;29.06,-31.22,;30.39,-32,;31.73,-31.23,;31.73,-29.69,;33.06,-32.01,;33.05,-33.54,;34.38,-34.31,;35.71,-33.55,;35.71,-32,;34.38,-31.23,;37.05,-31.23,;38.38,-32,;37.05,-29.69,;38.38,-30.45,)| InChI=1S/C27H33F3N4O3/c1-33(2)23-8-4-6-19(14-23)26(37)11-9-22(10-12-26)34-16-21(17-34)32-24(35)15-31-25(36)18-5-3-7-20(13-18)27(28,29)30/h3-8,13-14,21-22,37H,9-12,15-17H2,1-2H3,(H,31,36)(H,32,35) DUXDQMNXPCZQLV-UHFFFAOYSA-N 50353194 CHEMBL1829631 C-C chemokine receptor type 2 Homo sapiens 22 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353194 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353194&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49764446 136359880 CHEMBL1829631 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660964 O[C@@]1(CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1ccccc1 |r,wD:4.7,1.0,(-9.36,-27.63,;-8.26,-28.72,;-8.26,-27.18,;-6.93,-26.41,;-5.6,-27.18,;-5.6,-28.72,;-6.93,-29.49,;-4.26,-26.42,;-2.78,-26.83,;-2.37,-25.34,;-3.86,-24.94,;-1.04,-24.57,;.29,-25.35,;.29,-26.89,;1.63,-24.58,;2.96,-25.35,;4.3,-24.59,;4.3,-23.05,;5.63,-25.36,;5.61,-26.9,;6.94,-27.67,;8.28,-26.91,;8.28,-25.36,;6.95,-24.59,;9.61,-24.59,;10.95,-25.36,;9.61,-23.05,;10.94,-23.81,;-9.59,-29.49,;-9.59,-31.03,;-10.91,-31.8,;-12.26,-31.03,;-12.27,-29.48,;-10.93,-28.72,)| InChI=1S/C25H28F3N3O3/c26-25(27,28)19-8-4-5-17(13-19)23(33)29-14-22(32)30-20-15-31(16-20)21-9-11-24(34,12-10-21)18-6-2-1-3-7-18/h1-8,13,20-21,34H,9-12,14-16H2,(H,29,33)(H,30,32) QCPLMEBVJKAVGY-UHFFFAOYSA-N 50353197 CHEMBL1829628 C-C chemokine receptor type 2 Homo sapiens 55 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353197 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353197&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 46927116 136359883 CHEMBL1829628 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660965 Nc1cccnc1[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:7.7,wD:10.14,(-5.78,-48.09,;-7.11,-47.33,;-8.44,-48.1,;-9.78,-47.34,;-9.79,-45.79,;-8.45,-45.02,;-7.12,-45.8,;-5.79,-45.03,;-5.79,-43.49,;-4.46,-42.71,;-3.13,-43.49,;-3.13,-45.03,;-4.46,-45.79,;-1.79,-42.73,;-.3,-43.13,;.1,-41.64,;-1.39,-41.24,;1.44,-40.88,;2.77,-41.65,;2.76,-43.19,;4.1,-40.88,;5.43,-41.66,;6.77,-40.89,;6.77,-39.35,;8.1,-41.67,;8.09,-43.2,;9.42,-43.97,;10.75,-43.21,;10.75,-41.66,;9.42,-40.89,;12.09,-40.89,;13.42,-41.66,;12.09,-39.35,;13.42,-40.11,)| InChI=1S/C24H28F3N5O2/c25-24(26,27)17-4-1-3-16(11-17)23(34)30-12-21(33)31-18-13-32(14-18)19-8-6-15(7-9-19)22-20(28)5-2-10-29-22/h1-5,10-11,15,18-19H,6-9,12-14,28H2,(H,30,34)(H,31,33) WTXGXHROIBXUJC-UHFFFAOYSA-N 50353200 CHEMBL1829626 C-C chemokine receptor type 2 Homo sapiens 35 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353200&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 46945254 136359886 CHEMBL1829626 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660966 Oc1cnccc1[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:7.7,wD:10.14,(16.43,-33.33,;16.42,-34.87,;15.08,-35.63,;15.09,-37.18,;16.43,-37.95,;17.76,-37.17,;17.75,-35.64,;19.09,-34.87,;19.09,-33.33,;20.42,-32.55,;21.74,-33.33,;21.74,-34.87,;20.42,-35.63,;23.08,-32.57,;24.57,-32.97,;24.97,-31.48,;23.49,-31.08,;26.31,-30.72,;27.64,-31.49,;27.64,-33.03,;28.98,-30.73,;30.31,-31.5,;31.64,-30.73,;31.65,-29.19,;32.98,-31.51,;32.96,-33.04,;34.29,-33.82,;35.63,-33.05,;35.63,-31.5,;34.3,-30.73,;36.96,-30.73,;38.29,-31.5,;36.96,-29.19,;38.29,-29.95,)| InChI=1S/C24H27F3N4O3/c25-24(26,27)17-3-1-2-16(10-17)23(34)29-12-22(33)30-18-13-31(14-18)19-6-4-15(5-7-19)20-8-9-28-11-21(20)32/h1-3,8-11,15,18-19,32H,4-7,12-14H2,(H,29,34)(H,30,33) OWGBFYYPIAIMDH-UHFFFAOYSA-N 50353201 CHEMBL1829625 C-C chemokine receptor type 2 Homo sapiens 57 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353201 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353201&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 46944855 136359887 CHEMBL1829625 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660967 Oc1ccc(nc1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:7.7,wD:10.14,(-11.29,-40.7,;-9.96,-39.92,;-8.62,-40.69,;-7.29,-39.92,;-7.3,-38.38,;-8.63,-37.61,;-9.97,-38.37,;-5.97,-37.61,;-5.97,-36.07,;-4.64,-35.3,;-3.31,-36.07,;-3.31,-37.61,;-4.64,-38.38,;-1.97,-35.31,;-.48,-35.72,;-.08,-34.23,;-1.57,-33.83,;1.26,-33.46,;2.59,-34.24,;2.58,-35.78,;3.92,-33.47,;5.26,-34.24,;6.59,-33.48,;6.6,-31.94,;7.92,-34.25,;7.91,-35.79,;9.24,-36.56,;10.58,-35.8,;10.58,-34.25,;9.24,-33.48,;11.91,-33.48,;13.24,-34.25,;11.91,-31.94,;13.24,-32.7,)| InChI=1S/C24H27F3N4O3/c25-24(26,27)17-3-1-2-16(10-17)23(34)29-12-22(33)30-18-13-31(14-18)19-6-4-15(5-7-19)21-9-8-20(32)11-28-21/h1-3,8-11,15,18-19,32H,4-7,12-14H2,(H,29,34)(H,30,33) ZXLRVOHADIRDTA-UHFFFAOYSA-N 50353202 CHEMBL1829624 C-C chemokine receptor type 2 Homo sapiens 14 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353202 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353202&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 46947816 136359888 CHEMBL1829624 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660968 COc1cc(ccn1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:8.8,wD:11.15,(15.97,-23.81,;14.64,-23.05,;14.63,-21.51,;15.95,-20.74,;15.95,-19.2,;14.62,-18.43,;13.28,-19.19,;13.29,-20.74,;17.28,-18.43,;17.28,-16.89,;18.61,-16.12,;19.94,-16.89,;19.94,-18.43,;18.61,-19.2,;21.28,-16.13,;22.77,-16.54,;23.17,-15.05,;21.68,-14.65,;24.5,-14.28,;25.84,-15.06,;25.83,-16.6,;27.17,-14.29,;28.5,-15.06,;29.84,-14.3,;29.84,-12.76,;31.17,-15.07,;31.16,-16.61,;32.49,-17.38,;33.82,-16.62,;33.82,-15.07,;32.49,-14.3,;35.16,-14.3,;36.49,-15.07,;35.16,-12.76,;36.49,-13.52,)| InChI=1S/C25H29F3N4O3/c1-35-23-12-17(9-10-29-23)16-5-7-21(8-6-16)32-14-20(15-32)31-22(33)13-30-24(34)18-3-2-4-19(11-18)25(26,27)28/h2-4,9-12,16,20-21H,5-8,13-15H2,1H3,(H,30,34)(H,31,33) KTQOBGHRYHVWCO-UHFFFAOYSA-N 50353218 CHEMBL1829621 C-C chemokine receptor type 2 Homo sapiens 170 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353218 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353218&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 46944853 136359904 CHEMBL1829621 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660969 COc1cnccc1[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:8.8,wD:11.15,(-6.76,-16.65,;-8.1,-17.41,;-8.1,-18.95,;-9.44,-19.72,;-9.43,-21.27,;-8.09,-22.03,;-6.76,-21.26,;-6.77,-19.73,;-5.44,-18.95,;-5.44,-17.41,;-4.11,-16.64,;-2.78,-17.41,;-2.78,-18.95,;-4.11,-19.72,;-1.44,-16.65,;.05,-17.06,;.45,-15.57,;-1.04,-15.17,;1.79,-14.8,;3.12,-15.58,;3.11,-17.12,;4.45,-14.81,;5.78,-15.59,;7.12,-14.82,;7.12,-13.28,;8.45,-15.59,;8.44,-17.13,;9.77,-17.9,;11.1,-17.14,;11.1,-15.59,;9.77,-14.82,;12.44,-14.82,;13.77,-15.59,;12.44,-13.28,;13.77,-14.04,)| InChI=1S/C25H29F3N4O3/c1-35-22-12-29-10-9-21(22)16-5-7-20(8-6-16)32-14-19(15-32)31-23(33)13-30-24(34)17-3-2-4-18(11-17)25(26,27)28/h2-4,9-12,16,19-20H,5-8,13-15H2,1H3,(H,30,34)(H,31,33) JBYSLYJGZMRBFN-UHFFFAOYSA-N 50353204 CHEMBL1829620 C-C chemokine receptor type 2 Homo sapiens 28 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353204 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353204&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 46944854 136359890 CHEMBL1829620 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660970 COc1ccc(cn1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:8.8,wD:11.15,(10.22,-11.72,;11.56,-12.48,;12.89,-11.71,;12.88,-10.16,;14.22,-9.39,;15.55,-10.17,;15.56,-11.7,;14.23,-12.47,;16.89,-9.4,;16.89,-7.86,;18.21,-7.08,;19.54,-7.86,;19.54,-9.4,;18.21,-10.16,;20.88,-7.1,;22.37,-7.5,;22.77,-6.01,;21.29,-5.61,;24.11,-5.25,;25.44,-6.02,;25.43,-7.56,;26.78,-5.25,;28.11,-6.03,;29.44,-5.26,;29.45,-3.72,;30.77,-6.04,;30.76,-7.57,;32.09,-8.34,;33.43,-7.58,;33.43,-6.03,;32.1,-5.26,;34.76,-5.26,;36.09,-6.03,;34.76,-3.72,;36.09,-4.48,)| InChI=1S/C25H29F3N4O3/c1-35-23-10-7-18(12-29-23)16-5-8-21(9-6-16)32-14-20(15-32)31-22(33)13-30-24(34)17-3-2-4-19(11-17)25(26,27)28/h2-4,7,10-12,16,20-21H,5-6,8-9,13-15H2,1H3,(H,30,34)(H,31,33) PWZJJDJNMPHXPO-UHFFFAOYSA-N 50353205 CHEMBL1829619 C-C chemokine receptor type 2 Homo sapiens 11 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353205 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353205&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 46927117 136359891 CHEMBL1829619 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660971 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@@H](CC1)c1cccnc1 |r,wU:24.29,wD:21.22,(14.18,-6.67,;12.85,-5.9,;12.85,-4.36,;14.18,-5.13,;11.52,-6.67,;11.52,-8.22,;10.18,-8.99,;8.85,-8.22,;8.86,-6.68,;10.19,-5.91,;7.53,-5.91,;7.54,-4.37,;6.2,-6.67,;4.87,-5.9,;3.53,-6.66,;3.52,-8.2,;2.2,-5.89,;.86,-6.66,;.46,-8.14,;-1.03,-7.74,;-.62,-6.25,;-2.37,-8.5,;-3.7,-7.72,;-5.02,-8.5,;-5.02,-10.04,;-3.7,-10.8,;-2.37,-10.04,;-6.36,-10.81,;-7.69,-10.04,;-9.03,-10.8,;-9.02,-12.35,;-7.68,-13.12,;-6.35,-12.34,)| InChI=1S/C24H27F3N4O2/c25-24(26,27)19-5-1-3-17(11-19)23(33)29-13-22(32)30-20-14-31(15-20)21-8-6-16(7-9-21)18-4-2-10-28-12-18/h1-5,10-12,16,20-21H,6-9,13-15H2,(H,29,33)(H,30,32) BAZCORFCZVDJNX-UHFFFAOYSA-N 50353206 CHEMBL1829618 C-C chemokine receptor type 2 Homo sapiens 52 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353206 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353206&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56667036 136359892 CHEMBL1829618 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660972 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@@H](CC1)c1ccc(cc1)N1CCCC1 |r,wU:24.29,wD:21.22,(17.01,5.96,;15.68,6.73,;15.68,8.27,;17.01,7.51,;14.35,5.96,;14.35,4.41,;13.01,3.64,;11.68,4.42,;11.7,5.95,;13.02,6.72,;10.36,6.72,;10.37,8.27,;9.03,5.96,;7.7,6.73,;6.36,5.97,;6.36,4.43,;5.03,6.74,;3.69,5.97,;3.29,4.49,;1.8,4.89,;2.21,6.38,;.46,4.13,;-.86,4.91,;-2.19,4.13,;-2.19,2.59,;-.86,1.83,;.46,2.59,;-3.53,1.82,;-4.86,2.59,;-6.2,1.83,;-6.19,.28,;-4.85,-.49,;-3.52,.29,;-7.53,-.49,;-8.93,.13,;-9.96,-1.02,;-9.18,-2.35,;-7.68,-2.02,)| InChI=1S/C29H35F3N4O2/c30-29(31,32)23-5-3-4-22(16-23)28(38)33-17-27(37)34-24-18-36(19-24)26-12-8-21(9-13-26)20-6-10-25(11-7-20)35-14-1-2-15-35/h3-7,10-11,16,21,24,26H,1-2,8-9,12-15,17-19H2,(H,33,38)(H,34,37) JZRORTLHTQXXDH-UHFFFAOYSA-N 50353208 CHEMBL1829616 C-C chemokine receptor type 2 Homo sapiens 240 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353208 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353208&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49763804 136359894 CHEMBL1829616 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660973 OC(=O)c1ccc(cc1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:9.9,wD:12.16,(14.46,-48.36,;15.8,-49.12,;15.8,-50.66,;17.13,-48.35,;17.12,-46.8,;18.46,-46.04,;19.79,-46.81,;19.8,-48.34,;18.47,-49.11,;21.12,-46.04,;21.12,-44.5,;22.45,-43.72,;23.78,-44.5,;23.78,-46.04,;22.45,-46.8,;25.12,-43.74,;26.61,-44.14,;27.01,-42.65,;25.52,-42.25,;28.35,-41.89,;29.68,-42.66,;29.67,-44.2,;31.01,-41.89,;32.35,-42.67,;33.68,-41.9,;33.69,-40.36,;35.01,-42.68,;35,-44.21,;36.33,-44.98,;37.67,-44.22,;37.67,-42.67,;36.33,-41.9,;39,-41.9,;40.33,-42.67,;39,-40.36,;40.33,-41.12,)| InChI=1S/C26H28F3N3O4/c27-26(28,29)20-3-1-2-19(12-20)24(34)30-13-23(33)31-21-14-32(15-21)22-10-8-17(9-11-22)16-4-6-18(7-5-16)25(35)36/h1-7,12,17,21-22H,8-11,13-15H2,(H,30,34)(H,31,33)(H,35,36) GSASYNLMWPJCFM-UHFFFAOYSA-N 50353209 CHEMBL1829615 C-C chemokine receptor type 2 Homo sapiens 1300 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353209 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353209&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49763686 136359895 CHEMBL1829615 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660974 COc1ccc(cc1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:8.8,wD:11.15,(-11.84,-42.24,;-10.51,-43.01,;-9.18,-42.23,;-7.83,-43,;-6.51,-42.23,;-6.51,-40.69,;-7.85,-39.92,;-9.18,-40.68,;-5.18,-39.92,;-5.18,-38.38,;-3.85,-37.61,;-2.52,-38.38,;-2.52,-39.92,;-3.85,-40.69,;-1.18,-37.62,;.3,-38.03,;.71,-36.54,;-.78,-36.14,;2.04,-35.77,;3.37,-36.55,;3.37,-38.09,;4.71,-35.78,;6.04,-36.55,;7.38,-35.79,;7.38,-34.25,;8.71,-36.56,;8.69,-38.1,;10.02,-38.87,;11.36,-38.11,;11.36,-36.56,;10.03,-35.79,;12.69,-35.79,;14.03,-36.56,;12.69,-34.25,;14.02,-35.01,)| InChI=1S/C26H30F3N3O3/c1-35-23-11-7-18(8-12-23)17-5-9-22(10-6-17)32-15-21(16-32)31-24(33)14-30-25(34)19-3-2-4-20(13-19)26(27,28)29/h2-4,7-8,11-13,17,21-22H,5-6,9-10,14-16H2,1H3,(H,30,34)(H,31,33) GJYACPVUIOTYOV-UHFFFAOYSA-N 50353212 CHEMBL1829612 C-C chemokine receptor type 2 Homo sapiens 25 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353212 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353212&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49763682 136359898 CHEMBL1829612 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660975 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@@H](CC1)c1ccccc1 |r,wU:24.29,wD:21.22,(36.3,-16.68,;34.96,-15.91,;34.96,-14.37,;36.29,-15.14,;33.63,-16.68,;33.63,-18.23,;32.29,-19,;30.96,-18.23,;30.98,-16.69,;32.3,-15.92,;29.64,-15.92,;29.65,-14.38,;28.31,-16.68,;26.98,-15.91,;25.64,-16.67,;25.64,-18.21,;24.31,-15.9,;22.97,-16.67,;22.57,-18.15,;21.08,-17.75,;21.49,-16.26,;19.75,-18.51,;18.42,-17.73,;17.09,-18.51,;17.09,-20.05,;18.42,-20.81,;19.75,-20.05,;15.76,-20.82,;15.76,-22.35,;14.43,-23.13,;13.09,-22.36,;13.08,-20.81,;14.42,-20.05,)| InChI=1S/C25H28F3N3O2/c26-25(27,28)20-8-4-7-19(13-20)24(33)29-14-23(32)30-21-15-31(16-21)22-11-9-18(10-12-22)17-5-2-1-3-6-17/h1-8,13,18,21-22H,9-12,14-16H2,(H,29,33)(H,30,32) NMRHWRNUJPVSFE-UHFFFAOYSA-N 50353215 CHEMBL1829609 C-C chemokine receptor type 2 Homo sapiens 35 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353215 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353215&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49763571 136359901 CHEMBL1829609 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660976 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@H](CC1)c1ccc2OCOc2c1 |r,wU:21.22,24.29,(36.71,2.26,;35.37,3.03,;35.37,4.57,;36.7,3.81,;34.04,2.26,;34.04,.71,;32.7,-.05,;31.37,.72,;31.39,2.26,;32.71,3.03,;30.06,3.03,;30.06,4.57,;28.72,2.26,;27.39,3.04,;26.05,2.27,;26.05,.73,;24.72,3.05,;23.39,2.28,;22.98,.79,;21.5,1.2,;21.9,2.68,;20.16,.44,;20.16,-1.1,;18.83,-1.87,;17.5,-1.1,;17.5,.44,;18.83,1.21,;16.17,-1.88,;16.17,-3.41,;14.85,-4.18,;13.5,-3.41,;12.03,-3.9,;11.12,-2.65,;12.02,-1.39,;13.5,-1.87,;14.83,-1.1,)| InChI=1S/C26H28F3N3O4/c27-26(28,29)19-3-1-2-18(10-19)25(34)30-12-24(33)31-20-13-32(14-20)21-7-4-16(5-8-21)17-6-9-22-23(11-17)36-15-35-22/h1-3,6,9-11,16,20-21H,4-5,7-8,12-15H2,(H,30,34)(H,31,33) QTNRUICBYFHOBZ-UHFFFAOYSA-N 50353216 CHEMBL1829605 C-C chemokine receptor type 2 Homo sapiens 15 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353216 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353216&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49763568 136359902 CHEMBL1829605 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660977 OC[C@@]1(CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1ccccc1 |r,wU:2.31,wD:5.8,(-9.21,-17.37,;-9.2,-18.97,;-8.1,-20.07,;-8.1,-18.53,;-6.78,-17.75,;-5.45,-18.53,;-5.45,-20.07,;-6.78,-20.83,;-4.11,-17.77,;-2.62,-18.17,;-2.22,-16.68,;-3.7,-16.28,;-.88,-15.92,;.45,-16.69,;.44,-18.23,;1.79,-15.92,;3.12,-16.7,;4.45,-15.93,;4.46,-14.39,;5.78,-16.71,;5.77,-18.24,;7.1,-19.01,;8.44,-18.25,;8.44,-16.7,;7.11,-15.93,;9.77,-15.93,;11.1,-16.7,;9.77,-14.39,;11.1,-15.15,;-9.44,-20.84,;-9.43,-22.37,;-10.76,-23.14,;-12.1,-22.38,;-12.11,-20.83,;-10.77,-20.07,)| InChI=1S/C26H30F3N3O3/c27-26(28,29)20-8-4-5-18(13-20)24(35)30-14-23(34)31-21-15-32(16-21)22-9-11-25(17-33,12-10-22)19-6-2-1-3-7-19/h1-8,13,21-22,33H,9-12,14-17H2,(H,30,35)(H,31,34) RMJJBIQFUDVPQN-UHFFFAOYSA-N 50353219 CHEMBL1829640 C-C chemokine receptor type 2 Homo sapiens >25000 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353219 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353219&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56677291 136359905 CHEMBL1829640 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660978 OC(=O)[C@@]1(CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1ccccc1 |r,wU:3.32,wD:6.9,(16.55,-6.87,;16.15,-8.36,;14.66,-8.76,;17.24,-9.46,;17.24,-7.92,;18.57,-7.14,;19.9,-7.92,;19.9,-9.46,;18.57,-10.22,;21.24,-7.16,;22.73,-7.56,;23.13,-6.07,;21.64,-5.67,;24.47,-5.31,;25.8,-6.08,;25.79,-7.62,;27.13,-5.32,;28.46,-6.09,;29.8,-5.32,;29.8,-3.78,;31.13,-6.1,;31.12,-7.63,;32.45,-8.41,;33.78,-7.64,;33.78,-6.09,;32.45,-5.32,;35.12,-5.32,;36.45,-6.09,;35.12,-3.78,;36.45,-4.54,;15.91,-10.23,;15.92,-11.76,;14.59,-12.54,;13.25,-11.77,;13.24,-10.22,;14.58,-9.46,)| InChI=1S/C26H28F3N3O4/c27-26(28,29)19-8-4-5-17(13-19)23(34)30-14-22(33)31-20-15-32(16-20)21-9-11-25(12-10-21,24(35)36)18-6-2-1-3-7-18/h1-8,13,20-21H,9-12,14-16H2,(H,30,34)(H,31,33)(H,35,36) TWXZQXCPTUKUNZ-UHFFFAOYSA-N 50353220 CHEMBL1829639 C-C chemokine receptor type 2 Homo sapiens >25000 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353220 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353220&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56677290 136359906 CHEMBL1829639 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660979 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@](CC1)(C#N)c1ccccc1 |r,wU:24.31,wD:21.22,(12.67,-5.56,;11.34,-4.79,;11.34,-3.25,;12.67,-4.01,;10.01,-5.56,;10.01,-7.11,;8.67,-7.88,;7.34,-7.1,;7.36,-5.57,;8.68,-4.8,;6.02,-4.79,;6.03,-3.25,;4.69,-5.56,;3.36,-4.79,;2.02,-5.55,;2.02,-7.09,;.69,-4.78,;-.65,-5.54,;-1.05,-7.03,;-2.54,-6.63,;-2.13,-5.14,;-3.88,-7.39,;-5.2,-6.61,;-6.53,-7.39,;-6.53,-8.93,;-5.2,-9.69,;-3.88,-8.93,;-7.63,-7.83,;-8.73,-6.74,;-7.87,-9.7,;-7.86,-11.23,;-9.19,-12.01,;-10.53,-11.24,;-10.54,-9.69,;-9.2,-8.93,)| InChI=1S/C26H27F3N4O2/c27-26(28,29)20-8-4-5-18(13-20)24(35)31-14-23(34)32-21-15-33(16-21)22-9-11-25(17-30,12-10-22)19-6-2-1-3-7-19/h1-8,13,21-22H,9-12,14-16H2,(H,31,35)(H,32,34) NOTIHPOJUXGFAD-UHFFFAOYSA-N 50353221 CHEMBL1829638 C-C chemokine receptor type 2 Homo sapiens >25000 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353221 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353221&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56670477 136359907 CHEMBL1829638 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660980 N[C@@]1(CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1ccccc1 |r,wD:4.7,1.0,(13.25,1.68,;14.34,.58,;14.34,2.12,;15.67,2.9,;17,2.12,;17,.58,;15.67,-.18,;18.34,2.88,;19.83,2.48,;20.23,3.97,;18.74,4.37,;21.56,4.73,;22.9,3.96,;22.89,2.42,;24.23,4.73,;25.56,3.95,;26.9,4.72,;26.9,6.26,;28.23,3.94,;28.22,2.41,;29.55,1.64,;30.88,2.4,;30.88,3.95,;29.55,4.72,;32.22,4.72,;33.55,3.95,;32.22,6.26,;33.55,5.5,;13.01,-.19,;13.01,-1.72,;11.69,-2.49,;10.35,-1.73,;10.34,-.18,;11.68,.58,)| InChI=1S/C25H29F3N4O2/c26-25(27,28)19-8-4-5-17(13-19)23(34)30-14-22(33)31-20-15-32(16-20)21-9-11-24(29,12-10-21)18-6-2-1-3-7-18/h1-8,13,20-21H,9-12,14-16,29H2,(H,30,34)(H,31,33) CUVUMQNQHNMFND-UHFFFAOYSA-N 50353189 CHEMBL1829637 C-C chemokine receptor type 2 Homo sapiens 240 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353189 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353189&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49763575 136359875 CHEMBL1829637 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660981 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@@](F)(CC1)c1ccccc1 |r,wD:21.22,24.26,(13.62,4.95,;12.29,5.72,;12.29,7.26,;13.62,6.49,;10.96,4.95,;10.96,3.4,;9.62,2.63,;8.29,3.4,;8.3,4.94,;9.63,5.71,;6.97,5.71,;6.98,7.25,;5.64,4.95,;4.31,5.72,;2.97,4.96,;2.96,3.42,;1.64,5.73,;.3,4.96,;-.1,3.48,;-1.59,3.88,;-1.18,5.37,;-2.93,3.12,;-4.26,3.9,;-5.58,3.12,;-5.58,1.58,;-6.68,2.68,;-4.26,.82,;-2.93,1.58,;-6.92,.81,;-6.91,-.72,;-8.24,-1.5,;-9.58,-.73,;-9.59,.82,;-8.25,1.58,)| InChI=1S/C25H27F4N3O2/c26-24(18-6-2-1-3-7-18)11-9-21(10-12-24)32-15-20(16-32)31-22(33)14-30-23(34)17-5-4-8-19(13-17)25(27,28)29/h1-8,13,20-21H,9-12,14-16H2,(H,30,34)(H,31,33) UIXXHYJYOADLPS-UHFFFAOYSA-N 50353190 CHEMBL1829636 C-C chemokine receptor type 2 Homo sapiens 110 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353190 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353190&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49763574 136359876 CHEMBL1829636 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660982 Cc1cccc(C)c1[C@@]1(O)CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wD:12.16,8.9,(45.46,-49.44,;44.13,-48.67,;42.8,-49.45,;41.46,-48.68,;41.45,-47.13,;42.79,-46.37,;42.79,-44.83,;44.12,-47.14,;45.45,-46.37,;45.45,-47.91,;45.45,-44.83,;46.78,-44.05,;48.11,-44.83,;48.11,-46.37,;46.78,-47.13,;49.45,-44.07,;50.94,-44.47,;51.34,-42.99,;49.85,-42.58,;52.68,-42.22,;54.01,-42.99,;54,-44.53,;55.34,-42.23,;56.67,-43,;58.01,-42.24,;58.01,-40.7,;59.34,-43.01,;59.33,-44.55,;60.66,-45.32,;61.99,-44.55,;61.99,-43,;60.66,-42.24,;63.33,-42.23,;64.66,-43,;63.33,-40.69,;64.66,-41.46,)| InChI=1S/C27H32F3N3O3/c1-17-5-3-6-18(2)24(17)26(36)11-9-22(10-12-26)33-15-21(16-33)32-23(34)14-31-25(35)19-7-4-8-20(13-19)27(28,29)30/h3-8,13,21-22,36H,9-12,14-16H2,1-2H3,(H,31,35)(H,32,34) TZKCRWKVXTVJNJ-UHFFFAOYSA-N 50353191 CHEMBL1829635 C-C chemokine receptor type 2 Homo sapiens >25000 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353191 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353191&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56677289 136359877 CHEMBL1829635 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660983 O[C@@]1(CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1ccc2CCOc2c1 |r,wD:4.7,1.0,(45,-44.46,;46.1,-45.55,;46.1,-44.01,;47.43,-43.24,;48.76,-44.01,;48.76,-45.55,;47.43,-46.32,;50.1,-43.25,;51.58,-43.66,;51.99,-42.17,;50.5,-41.77,;53.32,-41.4,;54.65,-42.18,;54.65,-43.72,;55.99,-41.41,;57.32,-42.19,;58.66,-41.42,;58.66,-39.88,;59.99,-42.19,;59.97,-43.73,;61.3,-44.5,;62.64,-43.74,;62.64,-42.19,;61.31,-41.42,;63.97,-41.42,;65.31,-42.19,;63.97,-39.88,;65.3,-40.64,;44.77,-46.33,;43.43,-45.55,;42.09,-46.32,;42.1,-47.87,;40.96,-48.91,;41.6,-50.31,;43.13,-50.14,;43.45,-48.63,;44.77,-47.86,)| InChI=1S/C27H30F3N3O4/c28-27(29,30)20-3-1-2-18(12-20)25(35)31-14-24(34)32-21-15-33(16-21)22-6-9-26(36,10-7-22)19-5-4-17-8-11-37-23(17)13-19/h1-5,12-13,21-22,36H,6-11,14-16H2,(H,31,35)(H,32,34) MUASMHOMZSYLAM-UHFFFAOYSA-N 50353217 CHEMBL1829634 C-C chemokine receptor type 2 Homo sapiens 25 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353217&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56677288 136359903 CHEMBL1829634 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660984 O[C@@]1(CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1ccc2OCOc2c1 |r,wD:4.7,1.0,(20.7,-42.67,;21.79,-43.77,;21.79,-42.23,;23.12,-41.45,;24.45,-42.23,;24.45,-43.77,;23.12,-44.53,;25.79,-41.47,;27.28,-41.87,;27.68,-40.38,;26.19,-39.98,;29.02,-39.62,;30.35,-40.39,;30.34,-41.93,;31.68,-39.62,;33.01,-40.4,;34.35,-39.63,;34.35,-38.09,;35.68,-40.41,;35.67,-41.94,;37,-42.71,;38.33,-41.95,;38.33,-40.4,;37,-39.63,;39.67,-39.63,;41,-40.4,;39.67,-38.09,;41,-38.85,;20.46,-44.54,;19.13,-43.76,;17.79,-44.53,;17.8,-46.08,;16.66,-47.12,;17.29,-48.52,;18.83,-48.35,;19.14,-46.84,;20.47,-46.07,)| InChI=1S/C26H28F3N3O5/c27-26(28,29)18-3-1-2-16(10-18)24(34)30-12-23(33)31-19-13-32(14-19)20-6-8-25(35,9-7-20)17-4-5-21-22(11-17)37-15-36-21/h1-5,10-11,19-20,35H,6-9,12-15H2,(H,30,34)(H,31,33) JGTRPNAQMCJPRH-UHFFFAOYSA-N 50353192 CHEMBL1829633 C-C chemokine receptor type 2 Homo sapiens 22 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353192 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353192&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49764196 136359878 CHEMBL1829633 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660985 CN(C)c1cccc(c1)[C@@]1(O)CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wD:13.17,9.10,(15.2,-40.76,;16.53,-39.98,;17.86,-40.75,;16.52,-38.44,;15.18,-37.68,;15.17,-36.13,;16.51,-35.36,;17.84,-36.14,;17.84,-37.67,;19.17,-35.37,;18.08,-34.27,;19.17,-33.83,;20.5,-33.05,;21.83,-33.83,;21.83,-35.37,;20.5,-36.13,;23.17,-33.07,;24.66,-33.47,;25.06,-31.98,;23.57,-31.58,;26.39,-31.22,;27.73,-31.99,;27.72,-33.53,;29.06,-31.22,;30.39,-32,;31.73,-31.23,;31.73,-29.69,;33.06,-32.01,;33.05,-33.54,;34.38,-34.31,;35.71,-33.55,;35.71,-32,;34.38,-31.23,;37.05,-31.23,;38.38,-32,;37.05,-29.69,;38.38,-30.45,)| InChI=1S/C27H33F3N4O3/c1-33(2)23-8-4-6-19(14-23)26(37)11-9-22(10-12-26)34-16-21(17-34)32-24(35)15-31-25(36)18-5-3-7-20(13-18)27(28,29)30/h3-8,13-14,21-22,37H,9-12,15-17H2,1-2H3,(H,31,36)(H,32,35) DUXDQMNXPCZQLV-UHFFFAOYSA-N 50353194 CHEMBL1829631 C-C chemokine receptor type 2 Homo sapiens 15 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353194 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353194&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49764446 136359880 CHEMBL1829631 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660986 O[C@@]1(CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1cccc(c1)C#N |r,wD:4.7,1.0,(-7.84,-34.16,;-6.74,-35.26,;-6.74,-33.72,;-5.41,-32.94,;-4.09,-33.72,;-4.09,-35.26,;-5.41,-36.02,;-2.75,-32.96,;-1.26,-33.36,;-.86,-31.87,;-2.34,-31.47,;.48,-31.11,;1.81,-31.88,;1.81,-33.42,;3.15,-31.11,;4.48,-31.89,;5.81,-31.12,;5.82,-29.58,;7.15,-31.9,;7.13,-33.43,;8.46,-34.2,;9.8,-33.44,;9.8,-31.89,;8.47,-31.12,;11.13,-31.12,;12.46,-31.89,;11.13,-29.58,;12.46,-30.34,;-8.08,-36.03,;-9.41,-35.26,;-10.75,-36.02,;-10.74,-37.57,;-9.4,-38.33,;-8.07,-37.56,;-9.38,-39.88,;-9.38,-41.42,)| InChI=1S/C26H27F3N4O3/c27-26(28,29)20-6-2-4-18(12-20)24(35)31-14-23(34)32-21-15-33(16-21)22-7-9-25(36,10-8-22)19-5-1-3-17(11-19)13-30/h1-6,11-12,21-22,36H,7-10,14-16H2,(H,31,35)(H,32,34) LYTSOOZQXOHDBG-UHFFFAOYSA-N 50353195 CHEMBL1829630 C-C chemokine receptor type 2 Homo sapiens 410 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353195 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353195&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49764701 136359881 CHEMBL1829630 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660987 O[C@@]1(CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1ccc(F)cc1 |r,wD:4.7,1.0,(18.18,-24.52,;19.27,-25.62,;19.27,-24.08,;20.6,-23.3,;21.93,-24.08,;21.93,-25.62,;20.6,-26.38,;23.27,-23.32,;24.76,-23.72,;25.16,-22.24,;23.67,-21.83,;26.5,-21.47,;27.83,-22.24,;27.82,-23.78,;29.16,-21.48,;30.49,-22.25,;31.83,-21.49,;31.83,-19.95,;33.16,-22.26,;33.15,-23.79,;34.48,-24.57,;35.81,-23.8,;35.81,-22.25,;34.48,-21.49,;37.15,-21.48,;38.48,-22.25,;37.15,-19.94,;38.48,-20.7,;17.94,-26.39,;17.95,-27.92,;16.62,-28.7,;15.28,-27.93,;13.95,-28.71,;15.27,-26.38,;16.61,-25.62,)| InChI=1S/C25H27F4N3O3/c26-19-6-4-17(5-7-19)24(35)10-8-21(9-11-24)32-14-20(15-32)31-22(33)13-30-23(34)16-2-1-3-18(12-16)25(27,28)29/h1-7,12,20-21,35H,8-11,13-15H2,(H,30,34)(H,31,33) XULVMRUMTSIIFH-UHFFFAOYSA-N 50353196 CHEMBL1829629 C-C chemokine receptor type 2 Homo sapiens 210 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353196 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353196&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49764700 136359882 CHEMBL1829629 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660988 O[C@@]1(CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1ccccc1 |r,wD:4.7,1.0,(-9.36,-27.63,;-8.26,-28.72,;-8.26,-27.18,;-6.93,-26.41,;-5.6,-27.18,;-5.6,-28.72,;-6.93,-29.49,;-4.26,-26.42,;-2.78,-26.83,;-2.37,-25.34,;-3.86,-24.94,;-1.04,-24.57,;.29,-25.35,;.29,-26.89,;1.63,-24.58,;2.96,-25.35,;4.3,-24.59,;4.3,-23.05,;5.63,-25.36,;5.61,-26.9,;6.94,-27.67,;8.28,-26.91,;8.28,-25.36,;6.95,-24.59,;9.61,-24.59,;10.95,-25.36,;9.61,-23.05,;10.94,-23.81,;-9.59,-29.49,;-9.59,-31.03,;-10.91,-31.8,;-12.26,-31.03,;-12.27,-29.48,;-10.93,-28.72,)| InChI=1S/C25H28F3N3O3/c26-25(27,28)19-8-4-5-17(13-19)23(33)29-14-22(32)30-20-15-31(16-20)21-9-11-24(34,12-10-21)18-6-2-1-3-7-18/h1-8,13,20-21,34H,9-12,14-16H2,(H,29,33)(H,30,32) QCPLMEBVJKAVGY-UHFFFAOYSA-N 50353197 CHEMBL1829628 C-C chemokine receptor type 2 Homo sapiens 36 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353197 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353197&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 46927116 136359883 CHEMBL1829628 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660989 O[C@@]1(CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1cccnc1 |r,wD:4.7,1.0,(18.02,-17.13,;19.12,-18.23,;19.12,-16.69,;20.45,-15.91,;21.78,-16.69,;21.78,-18.23,;20.45,-18.99,;23.11,-15.93,;24.6,-16.33,;25,-14.85,;23.52,-14.44,;26.34,-14.08,;27.67,-14.85,;27.67,-16.39,;29.01,-14.09,;30.34,-14.86,;31.67,-14.1,;31.68,-12.56,;33.01,-14.87,;32.99,-16.41,;34.32,-17.18,;35.66,-16.41,;35.66,-14.86,;34.33,-14.1,;36.99,-14.09,;38.33,-14.86,;36.99,-12.55,;38.32,-13.32,;17.79,-19,;16.45,-18.23,;15.11,-18.99,;15.12,-20.54,;16.46,-21.31,;17.79,-20.53,)| InChI=1S/C24H27F3N4O3/c25-24(26,27)17-4-1-3-16(11-17)22(33)29-13-21(32)30-19-14-31(15-19)20-6-8-23(34,9-7-20)18-5-2-10-28-12-18/h1-5,10-12,19-20,34H,6-9,13-15H2,(H,29,33)(H,30,32) YBQZLWPFQRLDTC-UHFFFAOYSA-N 50353198 CHEMBL1829603 C-C chemokine receptor type 2 Homo sapiens 190 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353198 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353198&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 46241829 136359884 CHEMBL1829603 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660990 Nc1ccc(nc1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:7.7,wD:10.14,(10.98,-48.4,;12.31,-47.62,;13.65,-48.39,;14.97,-47.62,;14.97,-46.08,;13.64,-45.31,;12.3,-46.07,;16.3,-45.31,;16.3,-43.77,;17.63,-43,;18.96,-43.77,;18.96,-45.31,;17.63,-46.08,;20.3,-43.01,;21.79,-43.42,;22.19,-41.93,;20.7,-41.53,;23.52,-41.16,;24.86,-41.94,;24.85,-43.48,;26.19,-41.17,;27.52,-41.94,;28.86,-41.18,;28.86,-39.64,;30.19,-41.95,;30.18,-43.49,;31.51,-44.26,;32.84,-43.5,;32.84,-41.95,;31.51,-41.18,;34.18,-41.18,;35.51,-41.95,;34.18,-39.64,;35.51,-40.4,)| InChI=1S/C24H28F3N5O2/c25-24(26,27)17-3-1-2-16(10-17)23(34)30-12-22(33)31-19-13-32(14-19)20-7-4-15(5-8-20)21-9-6-18(28)11-29-21/h1-3,6,9-11,15,19-20H,4-5,7-8,12-14,28H2,(H,30,34)(H,31,33) UOPRHVPDLPNSEU-UHFFFAOYSA-N 50353199 CHEMBL1829627 C-C chemokine receptor type 2 Homo sapiens 85 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353199 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353199&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 46945255 136359885 CHEMBL1829627 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660991 Nc1cccnc1[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:7.7,wD:10.14,(-5.78,-48.09,;-7.11,-47.33,;-8.44,-48.1,;-9.78,-47.34,;-9.79,-45.79,;-8.45,-45.02,;-7.12,-45.8,;-5.79,-45.03,;-5.79,-43.49,;-4.46,-42.71,;-3.13,-43.49,;-3.13,-45.03,;-4.46,-45.79,;-1.79,-42.73,;-.3,-43.13,;.1,-41.64,;-1.39,-41.24,;1.44,-40.88,;2.77,-41.65,;2.76,-43.19,;4.1,-40.88,;5.43,-41.66,;6.77,-40.89,;6.77,-39.35,;8.1,-41.67,;8.09,-43.2,;9.42,-43.97,;10.75,-43.21,;10.75,-41.66,;9.42,-40.89,;12.09,-40.89,;13.42,-41.66,;12.09,-39.35,;13.42,-40.11,)| InChI=1S/C24H28F3N5O2/c25-24(26,27)17-4-1-3-16(11-17)23(34)30-12-21(33)31-18-13-32(14-18)19-8-6-15(7-9-19)22-20(28)5-2-10-29-22/h1-5,10-11,15,18-19H,6-9,12-14,28H2,(H,30,34)(H,31,33) WTXGXHROIBXUJC-UHFFFAOYSA-N 50353200 CHEMBL1829626 C-C chemokine receptor type 2 Homo sapiens 43 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353200 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353200&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 46945254 136359886 CHEMBL1829626 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660992 Oc1cnccc1[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:7.7,wD:10.14,(16.43,-33.33,;16.42,-34.87,;15.08,-35.63,;15.09,-37.18,;16.43,-37.95,;17.76,-37.17,;17.75,-35.64,;19.09,-34.87,;19.09,-33.33,;20.42,-32.55,;21.74,-33.33,;21.74,-34.87,;20.42,-35.63,;23.08,-32.57,;24.57,-32.97,;24.97,-31.48,;23.49,-31.08,;26.31,-30.72,;27.64,-31.49,;27.64,-33.03,;28.98,-30.73,;30.31,-31.5,;31.64,-30.73,;31.65,-29.19,;32.98,-31.51,;32.96,-33.04,;34.29,-33.82,;35.63,-33.05,;35.63,-31.5,;34.3,-30.73,;36.96,-30.73,;38.29,-31.5,;36.96,-29.19,;38.29,-29.95,)| InChI=1S/C24H27F3N4O3/c25-24(26,27)17-3-1-2-16(10-17)23(34)29-12-22(33)30-18-13-31(14-18)19-6-4-15(5-7-19)20-8-9-28-11-21(20)32/h1-3,8-11,15,18-19,32H,4-7,12-14H2,(H,29,34)(H,30,33) OWGBFYYPIAIMDH-UHFFFAOYSA-N 50353201 CHEMBL1829625 C-C chemokine receptor type 2 Homo sapiens 52 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353201 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353201&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 46944855 136359887 CHEMBL1829625 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660993 Oc1ccc(nc1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:7.7,wD:10.14,(-11.29,-40.7,;-9.96,-39.92,;-8.62,-40.69,;-7.29,-39.92,;-7.3,-38.38,;-8.63,-37.61,;-9.97,-38.37,;-5.97,-37.61,;-5.97,-36.07,;-4.64,-35.3,;-3.31,-36.07,;-3.31,-37.61,;-4.64,-38.38,;-1.97,-35.31,;-.48,-35.72,;-.08,-34.23,;-1.57,-33.83,;1.26,-33.46,;2.59,-34.24,;2.58,-35.78,;3.92,-33.47,;5.26,-34.24,;6.59,-33.48,;6.6,-31.94,;7.92,-34.25,;7.91,-35.79,;9.24,-36.56,;10.58,-35.8,;10.58,-34.25,;9.24,-33.48,;11.91,-33.48,;13.24,-34.25,;11.91,-31.94,;13.24,-32.7,)| InChI=1S/C24H27F3N4O3/c25-24(26,27)17-3-1-2-16(10-17)23(34)29-12-22(33)30-18-13-31(14-18)19-6-4-15(5-7-19)21-9-8-20(32)11-28-21/h1-3,8-11,15,18-19,32H,4-7,12-14H2,(H,29,34)(H,30,33) ZXLRVOHADIRDTA-UHFFFAOYSA-N 50353202 CHEMBL1829624 C-C chemokine receptor type 2 Homo sapiens 13 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353202 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353202&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 46947816 136359888 CHEMBL1829624 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660994 CN(C)c1ncc(cn1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:9.9,wD:12.16,(8.7,-29.27,;10.04,-30.03,;10.04,-31.57,;11.37,-29.25,;11.36,-27.7,;12.7,-26.94,;14.03,-27.71,;14.03,-29.25,;12.71,-30.02,;15.36,-26.94,;15.36,-25.4,;16.69,-24.62,;18.02,-25.4,;18.02,-26.94,;16.69,-27.7,;19.36,-24.64,;20.84,-25.04,;21.25,-23.56,;19.76,-23.16,;22.58,-22.79,;23.91,-23.57,;23.91,-25.11,;25.25,-22.8,;26.58,-23.57,;27.92,-22.81,;27.92,-21.27,;29.25,-23.58,;29.23,-25.12,;30.56,-25.89,;31.9,-25.12,;31.9,-23.58,;30.57,-22.81,;33.24,-22.81,;34.57,-23.57,;33.23,-21.27,;34.56,-22.03,)| InChI=1S/C25H31F3N6O2/c1-33(2)24-30-11-18(12-31-24)16-6-8-21(9-7-16)34-14-20(15-34)32-22(35)13-29-23(36)17-4-3-5-19(10-17)25(26,27)28/h3-5,10-12,16,20-21H,6-9,13-15H2,1-2H3,(H,29,36)(H,32,35) RMIZYUMWEUFFGE-UHFFFAOYSA-N 50353222 CHEMBL1829623 C-C chemokine receptor type 2 Homo sapiens 31 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353222 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353222&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 46946058 136359908 CHEMBL1829623 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660995 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@@H](CC1)c1cnccn1 |r,wU:24.29,wD:21.22,(12.97,-24.1,;11.64,-23.33,;11.64,-21.79,;12.97,-22.56,;10.3,-24.1,;10.3,-25.65,;8.97,-26.42,;7.64,-25.65,;7.65,-24.11,;8.97,-23.34,;6.32,-23.34,;6.32,-21.8,;4.98,-24.1,;3.65,-23.33,;2.32,-24.09,;2.31,-25.63,;.98,-23.32,;-.35,-24.09,;-.75,-25.57,;-2.24,-25.17,;-1.84,-23.68,;-3.58,-25.93,;-4.91,-25.15,;-6.24,-25.93,;-6.24,-27.47,;-4.91,-28.23,;-3.58,-27.47,;-7.57,-28.24,;-7.57,-29.77,;-8.89,-30.55,;-10.23,-29.78,;-10.24,-28.23,;-8.9,-27.47,)| InChI=1S/C23H26F3N5O2/c24-23(25,26)17-3-1-2-16(10-17)22(33)29-12-21(32)30-18-13-31(14-18)19-6-4-15(5-7-19)20-11-27-8-9-28-20/h1-3,8-11,15,18-19H,4-7,12-14H2,(H,29,33)(H,30,32) YCFZQCRYKACGKE-UHFFFAOYSA-N 50353203 CHEMBL1829622 C-C chemokine receptor type 2 Homo sapiens 44 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353203 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353203&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 46945857 136359889 CHEMBL1829622 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660996 COc1cc(ccn1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:8.8,wD:11.15,(15.97,-23.81,;14.64,-23.05,;14.63,-21.51,;15.95,-20.74,;15.95,-19.2,;14.62,-18.43,;13.28,-19.19,;13.29,-20.74,;17.28,-18.43,;17.28,-16.89,;18.61,-16.12,;19.94,-16.89,;19.94,-18.43,;18.61,-19.2,;21.28,-16.13,;22.77,-16.54,;23.17,-15.05,;21.68,-14.65,;24.5,-14.28,;25.84,-15.06,;25.83,-16.6,;27.17,-14.29,;28.5,-15.06,;29.84,-14.3,;29.84,-12.76,;31.17,-15.07,;31.16,-16.61,;32.49,-17.38,;33.82,-16.62,;33.82,-15.07,;32.49,-14.3,;35.16,-14.3,;36.49,-15.07,;35.16,-12.76,;36.49,-13.52,)| InChI=1S/C25H29F3N4O3/c1-35-23-12-17(9-10-29-23)16-5-7-21(8-6-16)32-14-20(15-32)31-22(33)13-30-24(34)18-3-2-4-19(11-18)25(26,27)28/h2-4,9-12,16,20-21H,5-8,13-15H2,1H3,(H,30,34)(H,31,33) KTQOBGHRYHVWCO-UHFFFAOYSA-N 50353218 CHEMBL1829621 C-C chemokine receptor type 2 Homo sapiens 25 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353218 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353218&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 46944853 136359904 CHEMBL1829621 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660997 COc1cnccc1[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:8.8,wD:11.15,(-6.76,-16.65,;-8.1,-17.41,;-8.1,-18.95,;-9.44,-19.72,;-9.43,-21.27,;-8.09,-22.03,;-6.76,-21.26,;-6.77,-19.73,;-5.44,-18.95,;-5.44,-17.41,;-4.11,-16.64,;-2.78,-17.41,;-2.78,-18.95,;-4.11,-19.72,;-1.44,-16.65,;.05,-17.06,;.45,-15.57,;-1.04,-15.17,;1.79,-14.8,;3.12,-15.58,;3.11,-17.12,;4.45,-14.81,;5.78,-15.59,;7.12,-14.82,;7.12,-13.28,;8.45,-15.59,;8.44,-17.13,;9.77,-17.9,;11.1,-17.14,;11.1,-15.59,;9.77,-14.82,;12.44,-14.82,;13.77,-15.59,;12.44,-13.28,;13.77,-14.04,)| InChI=1S/C25H29F3N4O3/c1-35-22-12-29-10-9-21(22)16-5-7-20(8-6-16)32-14-19(15-32)31-23(33)13-30-24(34)17-3-2-4-18(11-17)25(26,27)28/h2-4,9-12,16,19-20H,5-8,13-15H2,1H3,(H,30,34)(H,31,33) JBYSLYJGZMRBFN-UHFFFAOYSA-N 50353204 CHEMBL1829620 C-C chemokine receptor type 2 Homo sapiens 32 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353204 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353204&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 46944854 136359890 CHEMBL1829620 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660998 COc1ccc(cn1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:8.8,wD:11.15,(10.22,-11.72,;11.56,-12.48,;12.89,-11.71,;12.88,-10.16,;14.22,-9.39,;15.55,-10.17,;15.56,-11.7,;14.23,-12.47,;16.89,-9.4,;16.89,-7.86,;18.21,-7.08,;19.54,-7.86,;19.54,-9.4,;18.21,-10.16,;20.88,-7.1,;22.37,-7.5,;22.77,-6.01,;21.29,-5.61,;24.11,-5.25,;25.44,-6.02,;25.43,-7.56,;26.78,-5.25,;28.11,-6.03,;29.44,-5.26,;29.45,-3.72,;30.77,-6.04,;30.76,-7.57,;32.09,-8.34,;33.43,-7.58,;33.43,-6.03,;32.1,-5.26,;34.76,-5.26,;36.09,-6.03,;34.76,-3.72,;36.09,-4.48,)| InChI=1S/C25H29F3N4O3/c1-35-23-10-7-18(12-29-23)16-5-8-21(9-6-16)32-14-20(15-32)31-22(33)13-30-24(34)17-3-2-4-19(11-17)25(26,27)28/h2-4,7,10-12,16,20-21H,5-6,8-9,13-15H2,1H3,(H,30,34)(H,31,33) PWZJJDJNMPHXPO-UHFFFAOYSA-N 50353205 CHEMBL1829619 C-C chemokine receptor type 2 Homo sapiens 7 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353205 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353205&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 46927117 136359891 CHEMBL1829619 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50660999 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@@H](CC1)c1cccnc1 |r,wU:24.29,wD:21.22,(14.18,-6.67,;12.85,-5.9,;12.85,-4.36,;14.18,-5.13,;11.52,-6.67,;11.52,-8.22,;10.18,-8.99,;8.85,-8.22,;8.86,-6.68,;10.19,-5.91,;7.53,-5.91,;7.54,-4.37,;6.2,-6.67,;4.87,-5.9,;3.53,-6.66,;3.52,-8.2,;2.2,-5.89,;.86,-6.66,;.46,-8.14,;-1.03,-7.74,;-.62,-6.25,;-2.37,-8.5,;-3.7,-7.72,;-5.02,-8.5,;-5.02,-10.04,;-3.7,-10.8,;-2.37,-10.04,;-6.36,-10.81,;-7.69,-10.04,;-9.03,-10.8,;-9.02,-12.35,;-7.68,-13.12,;-6.35,-12.34,)| InChI=1S/C24H27F3N4O2/c25-24(26,27)19-5-1-3-17(11-19)23(33)29-13-22(32)30-20-14-31(15-20)21-8-6-16(7-9-21)18-4-2-10-28-12-18/h1-5,10-12,16,20-21H,6-9,13-15H2,(H,29,33)(H,30,32) BAZCORFCZVDJNX-UHFFFAOYSA-N 50353206 CHEMBL1829618 C-C chemokine receptor type 2 Homo sapiens 45 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353206 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353206&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56667036 136359892 CHEMBL1829618 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50661000 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@@H](CC1)c1ccc(cc1)N1CCCC1 |r,wU:24.29,wD:21.22,(17.01,5.96,;15.68,6.73,;15.68,8.27,;17.01,7.51,;14.35,5.96,;14.35,4.41,;13.01,3.64,;11.68,4.42,;11.7,5.95,;13.02,6.72,;10.36,6.72,;10.37,8.27,;9.03,5.96,;7.7,6.73,;6.36,5.97,;6.36,4.43,;5.03,6.74,;3.69,5.97,;3.29,4.49,;1.8,4.89,;2.21,6.38,;.46,4.13,;-.86,4.91,;-2.19,4.13,;-2.19,2.59,;-.86,1.83,;.46,2.59,;-3.53,1.82,;-4.86,2.59,;-6.2,1.83,;-6.19,.28,;-4.85,-.49,;-3.52,.29,;-7.53,-.49,;-8.93,.13,;-9.96,-1.02,;-9.18,-2.35,;-7.68,-2.02,)| InChI=1S/C29H35F3N4O2/c30-29(31,32)23-5-3-4-22(16-23)28(38)33-17-27(37)34-24-18-36(19-24)26-12-8-21(9-13-26)20-6-10-25(11-7-20)35-14-1-2-15-35/h3-7,10-11,16,21,24,26H,1-2,8-9,12-15,17-19H2,(H,33,38)(H,34,37) JZRORTLHTQXXDH-UHFFFAOYSA-N 50353208 CHEMBL1829616 C-C chemokine receptor type 2 Homo sapiens 61 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353208 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353208&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49763804 136359894 CHEMBL1829616 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50661001 OC(=O)c1ccc(cc1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:9.9,wD:12.16,(14.46,-48.36,;15.8,-49.12,;15.8,-50.66,;17.13,-48.35,;17.12,-46.8,;18.46,-46.04,;19.79,-46.81,;19.8,-48.34,;18.47,-49.11,;21.12,-46.04,;21.12,-44.5,;22.45,-43.72,;23.78,-44.5,;23.78,-46.04,;22.45,-46.8,;25.12,-43.74,;26.61,-44.14,;27.01,-42.65,;25.52,-42.25,;28.35,-41.89,;29.68,-42.66,;29.67,-44.2,;31.01,-41.89,;32.35,-42.67,;33.68,-41.9,;33.69,-40.36,;35.01,-42.68,;35,-44.21,;36.33,-44.98,;37.67,-44.22,;37.67,-42.67,;36.33,-41.9,;39,-41.9,;40.33,-42.67,;39,-40.36,;40.33,-41.12,)| InChI=1S/C26H28F3N3O4/c27-26(28,29)20-3-1-2-19(12-20)24(34)30-13-23(33)31-21-14-32(15-21)22-10-8-17(9-11-22)16-4-6-18(7-5-16)25(35)36/h1-7,12,17,21-22H,8-11,13-15H2,(H,30,34)(H,31,33)(H,35,36) GSASYNLMWPJCFM-UHFFFAOYSA-N 50353209 CHEMBL1829615 C-C chemokine receptor type 2 Homo sapiens 70 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353209 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353209&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49763686 136359895 CHEMBL1829615 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50661002 COC(=O)c1ccc(cc1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:10.10,wD:13.17,(-13.75,-48.63,;-13.75,-50.17,;-12.41,-50.93,;-12.4,-52.47,;-11.07,-50.16,;-11.08,-48.61,;-9.74,-47.85,;-8.41,-48.62,;-8.41,-50.15,;-9.73,-50.93,;-7.08,-47.85,;-7.08,-46.31,;-5.75,-45.53,;-4.42,-46.31,;-4.42,-47.85,;-5.75,-48.61,;-3.08,-45.55,;-1.59,-45.95,;-1.19,-44.46,;-2.68,-44.06,;.14,-43.7,;1.48,-44.47,;1.47,-46.01,;2.81,-43.71,;4.14,-44.48,;5.48,-43.71,;5.48,-42.17,;6.81,-44.49,;6.8,-46.02,;8.13,-46.8,;9.46,-46.03,;9.46,-44.48,;8.13,-43.72,;10.8,-43.71,;12.13,-44.48,;10.8,-42.17,;12.13,-42.93,)| InChI=1S/C27H30F3N3O4/c1-37-26(36)19-7-5-17(6-8-19)18-9-11-23(12-10-18)33-15-22(16-33)32-24(34)14-31-25(35)20-3-2-4-21(13-20)27(28,29)30/h2-8,13,18,22-23H,9-12,14-16H2,1H3,(H,31,35)(H,32,34) PUGUKUOQIIUORX-UHFFFAOYSA-N 50353210 CHEMBL1829614 C-C chemokine receptor type 2 Homo sapiens 80 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353210 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353210&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49763685 136359896 CHEMBL1829614 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50661003 Oc1ccc(cc1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:7.7,wD:10.14,(12.86,-42.14,;14.19,-41.36,;15.53,-42.13,;16.86,-41.36,;16.85,-39.82,;15.52,-39.05,;14.18,-39.81,;18.18,-39.05,;18.18,-37.51,;19.51,-36.73,;20.84,-37.51,;20.84,-39.05,;19.51,-39.81,;22.18,-36.75,;23.67,-37.15,;24.07,-35.67,;22.58,-35.27,;25.41,-34.9,;26.74,-35.68,;26.73,-37.22,;28.07,-34.91,;29.41,-35.68,;30.74,-34.92,;30.75,-33.38,;32.07,-35.69,;32.06,-37.23,;33.39,-38,;34.73,-37.23,;34.73,-35.69,;33.39,-34.92,;36.06,-34.92,;37.39,-35.68,;36.06,-33.38,;37.39,-34.14,)| InChI=1S/C25H28F3N3O3/c26-25(27,28)19-3-1-2-18(12-19)24(34)29-13-23(33)30-20-14-31(15-20)21-8-4-16(5-9-21)17-6-10-22(32)11-7-17/h1-3,6-7,10-12,16,20-21,32H,4-5,8-9,13-15H2,(H,29,34)(H,30,33) VJYPOQFOBLLZGR-UHFFFAOYSA-N 50353211 CHEMBL1829613 C-C chemokine receptor type 2 Homo sapiens 21 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353211 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353211&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49764447 136359897 CHEMBL1829613 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50661004 COc1ccc(cc1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:8.8,wD:11.15,(-11.84,-42.24,;-10.51,-43.01,;-9.18,-42.23,;-7.83,-43,;-6.51,-42.23,;-6.51,-40.69,;-7.85,-39.92,;-9.18,-40.68,;-5.18,-39.92,;-5.18,-38.38,;-3.85,-37.61,;-2.52,-38.38,;-2.52,-39.92,;-3.85,-40.69,;-1.18,-37.62,;.3,-38.03,;.71,-36.54,;-.78,-36.14,;2.04,-35.77,;3.37,-36.55,;3.37,-38.09,;4.71,-35.78,;6.04,-36.55,;7.38,-35.79,;7.38,-34.25,;8.71,-36.56,;8.69,-38.1,;10.02,-38.87,;11.36,-38.11,;11.36,-36.56,;10.03,-35.79,;12.69,-35.79,;14.03,-36.56,;12.69,-34.25,;14.02,-35.01,)| InChI=1S/C26H30F3N3O3/c1-35-23-11-7-18(8-12-23)17-5-9-22(10-6-17)32-15-21(16-32)31-24(33)14-30-25(34)19-3-2-4-20(13-19)26(27,28)29/h2-4,7-8,11-13,17,21-22H,5-6,9-10,14-16H2,1H3,(H,30,34)(H,31,33) GJYACPVUIOTYOV-UHFFFAOYSA-N 50353212 CHEMBL1829612 C-C chemokine receptor type 2 Homo sapiens 10 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353212 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353212&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49763682 136359898 CHEMBL1829612 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50661005 FC(F)(F)c1ccc(cc1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@@H](CC1)c1ccc2OCOc2c1 |r,wU:24.29,wD:21.22,(33.58,-29.8,;33.58,-28.26,;34.92,-27.49,;34.91,-29.03,;32.25,-27.49,;30.91,-28.25,;29.58,-27.48,;29.6,-25.95,;30.92,-25.17,;32.25,-25.94,;28.27,-25.17,;28.27,-23.63,;26.93,-25.94,;25.6,-25.16,;24.26,-25.93,;24.26,-27.47,;22.93,-25.16,;21.6,-25.92,;21.19,-27.41,;19.71,-27.01,;20.11,-25.52,;18.37,-27.77,;17.04,-26.99,;15.71,-27.77,;15.71,-29.31,;17.04,-30.07,;18.37,-29.31,;14.38,-30.08,;14.38,-31.61,;13.06,-32.38,;11.71,-31.62,;10.24,-32.1,;9.33,-30.85,;10.23,-29.6,;11.71,-30.07,;13.05,-29.31,)| InChI=1S/C26H28F3N3O4/c27-26(28,29)19-6-1-17(2-7-19)25(34)30-12-24(33)31-20-13-32(14-20)21-8-3-16(4-9-21)18-5-10-22-23(11-18)36-15-35-22/h1-2,5-7,10-11,16,20-21H,3-4,8-9,12-15H2,(H,30,34)(H,31,33) ZKCFIHVGKYMOOL-UHFFFAOYSA-N 50353213 CHEMBL1829611 C-C chemokine receptor type 2 Homo sapiens 1200 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353213 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353213&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56677296 136359899 CHEMBL1829611 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50661006 O=C(CNC(=O)c1ccccc1)NC1CN(C1)[C@H]1CC[C@@H](CC1)c1ccc2OCOc2c1 |r,wU:20.25,wD:17.18,(3.49,-27.07,;3.5,-25.53,;4.83,-24.77,;6.17,-25.54,;7.5,-24.78,;7.51,-23.24,;8.83,-25.55,;8.82,-27.08,;10.15,-27.86,;11.49,-27.09,;11.49,-25.54,;10.15,-24.78,;2.17,-24.76,;.83,-25.53,;.43,-27.01,;-1.06,-26.61,;-.66,-25.12,;-2.4,-27.37,;-3.73,-26.59,;-5.06,-27.37,;-5.06,-28.91,;-3.73,-29.67,;-2.4,-28.91,;-6.39,-29.68,;-6.38,-31.21,;-7.71,-31.99,;-9.05,-31.22,;-10.52,-31.71,;-11.44,-30.46,;-10.53,-29.2,;-9.06,-29.67,;-7.72,-28.91,)| InChI=1S/C25H29N3O4/c29-24(13-26-25(30)18-4-2-1-3-5-18)27-20-14-28(15-20)21-9-6-17(7-10-21)19-8-11-22-23(12-19)32-16-31-22/h1-5,8,11-12,17,20-21H,6-7,9-10,13-16H2,(H,26,30)(H,27,29) VLGQQGBAZGCDNJ-UHFFFAOYSA-N 50353214 CHEMBL1829610 C-C chemokine receptor type 2 Homo sapiens 390 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353214 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353214&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49763569 136359900 CHEMBL1829610 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50661007 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@@H](CC1)c1ccccc1 |r,wU:24.29,wD:21.22,(36.3,-16.68,;34.96,-15.91,;34.96,-14.37,;36.29,-15.14,;33.63,-16.68,;33.63,-18.23,;32.29,-19,;30.96,-18.23,;30.98,-16.69,;32.3,-15.92,;29.64,-15.92,;29.65,-14.38,;28.31,-16.68,;26.98,-15.91,;25.64,-16.67,;25.64,-18.21,;24.31,-15.9,;22.97,-16.67,;22.57,-18.15,;21.08,-17.75,;21.49,-16.26,;19.75,-18.51,;18.42,-17.73,;17.09,-18.51,;17.09,-20.05,;18.42,-20.81,;19.75,-20.05,;15.76,-20.82,;15.76,-22.35,;14.43,-23.13,;13.09,-22.36,;13.08,-20.81,;14.42,-20.05,)| InChI=1S/C25H28F3N3O2/c26-25(27,28)20-8-4-7-19(13-20)24(33)29-14-23(32)30-21-15-31(16-21)22-11-9-18(10-12-22)17-5-2-1-3-6-17/h1-8,13,18,21-22H,9-12,14-16H2,(H,29,33)(H,30,32) NMRHWRNUJPVSFE-UHFFFAOYSA-N 50353215 CHEMBL1829609 C-C chemokine receptor type 2 Homo sapiens 35 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353215 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353215&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49763571 136359901 CHEMBL1829609 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50661008 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)C1CCC(=CC1)c1ccc2OCOc2c1 |c:26| InChI=1S/C26H26F3N3O4/c27-26(28,29)19-3-1-2-18(10-19)25(34)30-12-24(33)31-20-13-32(14-20)21-7-4-16(5-8-21)17-6-9-22-23(11-17)36-15-35-22/h1-4,6,9-11,20-21H,5,7-8,12-15H2,(H,30,34)(H,31,33) GYICATPFUUQVPD-UHFFFAOYSA-N 50353223 CHEMBL1829607 C-C chemokine receptor type 2 Homo sapiens 1000 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353223 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353223&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56680600 136359909 CHEMBL1829607 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50661009 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@@H](CC1)c1ccc2OCOc2c1 |r,wU:24.29,wD:21.22,(21.69,-1.51,;20.35,-.75,;20.33,.79,;21.67,.04,;19.03,-1.54,;19.04,-3.09,;17.71,-3.87,;16.37,-3.11,;16.37,-1.57,;17.69,-.78,;15.03,-.81,;15.02,.73,;13.71,-1.59,;12.37,-.83,;11.04,-1.61,;11.05,-3.15,;9.7,-.85,;8.37,-1.63,;8.4,-3.17,;6.86,-3.2,;6.83,-1.66,;5.52,-3.96,;4.19,-3.18,;2.86,-3.96,;2.86,-5.5,;4.19,-6.26,;5.52,-5.5,;1.53,-6.27,;1.53,-7.8,;.21,-8.58,;-1.13,-7.81,;-2.6,-8.29,;-3.52,-7.05,;-2.62,-5.79,;-1.14,-6.26,;.2,-5.5,)| InChI=1S/C26H28F3N3O4/c27-26(28,29)19-3-1-2-18(10-19)25(34)30-12-24(33)31-20-13-32(14-20)21-7-4-16(5-8-21)17-6-9-22-23(11-17)36-15-35-22/h1-3,6,9-11,16,20-21H,4-5,7-8,12-15H2,(H,30,34)(H,31,33) QTNRUICBYFHOBZ-UHFFFAOYSA-N 50353224 CHEMBL1829606 C-C chemokine receptor type 2 Homo sapiens 1800 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353224 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353224&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49763568 136359910 CHEMBL1829606 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50661010 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@H](CC1)c1ccc2OCOc2c1 |r,wU:21.22,24.29,(36.71,2.26,;35.37,3.03,;35.37,4.57,;36.7,3.81,;34.04,2.26,;34.04,.71,;32.7,-.05,;31.37,.72,;31.39,2.26,;32.71,3.03,;30.06,3.03,;30.06,4.57,;28.72,2.26,;27.39,3.04,;26.05,2.27,;26.05,.73,;24.72,3.05,;23.39,2.28,;22.98,.79,;21.5,1.2,;21.9,2.68,;20.16,.44,;20.16,-1.1,;18.83,-1.87,;17.5,-1.1,;17.5,.44,;18.83,1.21,;16.17,-1.88,;16.17,-3.41,;14.85,-4.18,;13.5,-3.41,;12.03,-3.9,;11.12,-2.65,;12.02,-1.39,;13.5,-1.87,;14.83,-1.1,)| InChI=1S/C26H28F3N3O4/c27-26(28,29)19-3-1-2-18(10-19)25(34)30-12-24(33)31-20-13-32(14-20)21-7-4-16(5-8-21)17-6-9-22-23(11-17)36-15-35-22/h1-3,6,9-11,16,20-21H,4-5,7-8,12-15H2,(H,30,34)(H,31,33) QTNRUICBYFHOBZ-UHFFFAOYSA-N 50353216 CHEMBL1829605 C-C chemokine receptor type 2 Homo sapiens 5 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353216 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353216&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49763568 136359902 CHEMBL1829605 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50661011 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)C1CCN(CC1)c1ccc2OCOc2c1 InChI=1S/C25H27F3N4O4/c26-25(27,28)17-3-1-2-16(10-17)24(34)29-12-23(33)30-18-13-32(14-18)19-6-8-31(9-7-19)20-4-5-21-22(11-20)36-15-35-21/h1-5,10-11,18-19H,6-9,12-15H2,(H,29,34)(H,30,33) XOWSJOWUNKXCJR-UHFFFAOYSA-N 50353225 CHEMBL1829608 C-C chemokine receptor type 2 Homo sapiens >25000 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353225 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353225&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 56677295 136359911 CHEMBL1829608 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50661012 CN(C)c1ncc(cn1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:9.9,wD:12.16,(8.7,-29.27,;10.04,-30.03,;10.04,-31.57,;11.37,-29.25,;11.36,-27.7,;12.7,-26.94,;14.03,-27.71,;14.03,-29.25,;12.71,-30.02,;15.36,-26.94,;15.36,-25.4,;16.69,-24.62,;18.02,-25.4,;18.02,-26.94,;16.69,-27.7,;19.36,-24.64,;20.84,-25.04,;21.25,-23.56,;19.76,-23.16,;22.58,-22.79,;23.91,-23.57,;23.91,-25.11,;25.25,-22.8,;26.58,-23.57,;27.92,-22.81,;27.92,-21.27,;29.25,-23.58,;29.23,-25.12,;30.56,-25.89,;31.9,-25.12,;31.9,-23.58,;30.57,-22.81,;33.24,-22.81,;34.57,-23.57,;33.23,-21.27,;34.56,-22.03,)| InChI=1S/C25H31F3N6O2/c1-33(2)24-30-11-18(12-31-24)16-6-8-21(9-7-16)34-14-20(15-34)32-22(35)13-29-23(36)17-4-3-5-19(10-17)25(26,27)28/h3-5,10-12,16,20-21H,6-9,13-15H2,1-2H3,(H,29,36)(H,32,35) RMIZYUMWEUFFGE-UHFFFAOYSA-N 50353222 CHEMBL1829623 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 9800 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353222 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353222&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 46946058 136359908 CHEMBL1829623 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50661013 N[C@@]1(CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1ccccc1 |r,wD:4.7,1.0,(13.25,1.68,;14.34,.58,;14.34,2.12,;15.67,2.9,;17,2.12,;17,.58,;15.67,-.18,;18.34,2.88,;19.83,2.48,;20.23,3.97,;18.74,4.37,;21.56,4.73,;22.9,3.96,;22.89,2.42,;24.23,4.73,;25.56,3.95,;26.9,4.72,;26.9,6.26,;28.23,3.94,;28.22,2.41,;29.55,1.64,;30.88,2.4,;30.88,3.95,;29.55,4.72,;32.22,4.72,;33.55,3.95,;32.22,6.26,;33.55,5.5,;13.01,-.19,;13.01,-1.72,;11.69,-2.49,;10.35,-1.73,;10.34,-.18,;11.68,.58,)| InChI=1S/C25H29F3N4O2/c26-25(27,28)19-8-4-5-17(13-19)23(34)30-14-22(33)31-20-15-32(16-20)21-9-11-24(29,12-10-21)18-6-2-1-3-7-18/h1-8,13,20-21H,9-12,14-16,29H2,(H,30,34)(H,31,33) CUVUMQNQHNMFND-UHFFFAOYSA-N 50353189 CHEMBL1829637 C-C chemokine receptor type 2 Homo sapiens 160 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353189 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353189&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49763575 136359875 CHEMBL1829637 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50661014 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@@H](CC1)c1ccc2nc[nH]c2c1 |r,wU:24.29,wD:21.22,(37.55,4.46,;36.21,5.23,;36.21,6.77,;37.54,6,;34.88,4.46,;34.88,2.91,;33.54,2.14,;32.21,2.91,;32.23,4.45,;33.55,5.22,;30.9,5.22,;30.9,6.76,;29.56,4.46,;28.23,5.23,;26.89,4.47,;26.89,2.93,;25.56,5.24,;24.23,4.47,;23.82,2.99,;22.34,3.39,;22.74,4.88,;21,2.63,;19.67,3.41,;18.34,2.63,;18.34,1.09,;19.67,.33,;21,1.09,;17.01,.32,;17.01,-1.21,;15.69,-1.99,;14.34,-1.22,;12.87,-1.71,;11.95,-.46,;12.86,.8,;14.34,.33,;15.67,1.09,)| InChI=1S/C26H28F3N5O2/c27-26(28,29)19-3-1-2-18(10-19)25(36)30-12-24(35)33-20-13-34(14-20)21-7-4-16(5-8-21)17-6-9-22-23(11-17)32-15-31-22/h1-3,6,9-11,15-16,20-21H,4-5,7-8,12-14H2,(H,30,36)(H,31,32)(H,33,35) VKTHBCCPYLGDJQ-UHFFFAOYSA-N 50353207 CHEMBL1829617 C-C chemokine receptor type 2 Homo sapiens 21 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353207 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353207&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49763931 136359893 CHEMBL1829617 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50661015 COc1ccc(cc1)[C@@]1(O)CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wD:12.16,8.9,(-11.77,-46.08,;-10.44,-46.85,;-9.11,-46.07,;-7.76,-46.84,;-6.44,-46.06,;-6.44,-44.53,;-7.78,-43.76,;-9.11,-44.52,;-5.11,-43.76,;-6.21,-42.66,;-5.11,-42.22,;-3.78,-41.44,;-2.45,-42.22,;-2.45,-43.76,;-3.78,-44.52,;-1.11,-41.46,;.37,-41.86,;.78,-40.37,;-.71,-39.97,;2.11,-39.61,;3.44,-40.38,;3.44,-41.92,;4.78,-39.62,;6.11,-40.39,;7.45,-39.62,;7.45,-38.08,;8.78,-40.4,;8.76,-41.93,;10.09,-42.71,;11.43,-41.94,;11.43,-40.39,;10.1,-39.62,;12.76,-39.62,;14.1,-40.39,;12.76,-38.08,;14.09,-38.84,)| InChI=1S/C26H30F3N3O4/c1-36-22-7-5-18(6-8-22)25(35)11-9-21(10-12-25)32-15-20(16-32)31-23(33)14-30-24(34)17-3-2-4-19(13-17)26(27,28)29/h2-8,13,20-21,35H,9-12,14-16H2,1H3,(H,30,34)(H,31,33) UARNPVFEWLAVGQ-UHFFFAOYSA-N 50353193 CHEMBL1829632 C-C chemokine receptor type 2 Homo sapiens 20 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353193 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353193&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49764322 136359879 CHEMBL1829632 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50661016 O[C@@]1(CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1ccc2CCOc2c1 |r,wD:4.7,1.0,(45,-44.46,;46.1,-45.55,;46.1,-44.01,;47.43,-43.24,;48.76,-44.01,;48.76,-45.55,;47.43,-46.32,;50.1,-43.25,;51.58,-43.66,;51.99,-42.17,;50.5,-41.77,;53.32,-41.4,;54.65,-42.18,;54.65,-43.72,;55.99,-41.41,;57.32,-42.19,;58.66,-41.42,;58.66,-39.88,;59.99,-42.19,;59.97,-43.73,;61.3,-44.5,;62.64,-43.74,;62.64,-42.19,;61.31,-41.42,;63.97,-41.42,;65.31,-42.19,;63.97,-39.88,;65.3,-40.64,;44.77,-46.33,;43.43,-45.55,;42.09,-46.32,;42.1,-47.87,;40.96,-48.91,;41.6,-50.31,;43.13,-50.14,;43.45,-48.63,;44.77,-47.86,)| InChI=1S/C27H30F3N3O4/c28-27(29,30)20-3-1-2-18(12-20)25(35)31-14-24(34)32-21-15-33(16-21)22-6-9-26(36,10-7-22)19-5-4-17-8-11-37-23(17)13-19/h1-5,12-13,21-22,36H,6-11,14-16H2,(H,31,35)(H,32,34) MUASMHOMZSYLAM-UHFFFAOYSA-N 50353217 CHEMBL1829634 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 11700 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353217&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 56677288 136359903 CHEMBL1829634 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50661017 COc1cc(ccn1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:8.8,wD:11.15,(15.97,-23.81,;14.64,-23.05,;14.63,-21.51,;15.95,-20.74,;15.95,-19.2,;14.62,-18.43,;13.28,-19.19,;13.29,-20.74,;17.28,-18.43,;17.28,-16.89,;18.61,-16.12,;19.94,-16.89,;19.94,-18.43,;18.61,-19.2,;21.28,-16.13,;22.77,-16.54,;23.17,-15.05,;21.68,-14.65,;24.5,-14.28,;25.84,-15.06,;25.83,-16.6,;27.17,-14.29,;28.5,-15.06,;29.84,-14.3,;29.84,-12.76,;31.17,-15.07,;31.16,-16.61,;32.49,-17.38,;33.82,-16.62,;33.82,-15.07,;32.49,-14.3,;35.16,-14.3,;36.49,-15.07,;35.16,-12.76,;36.49,-13.52,)| InChI=1S/C25H29F3N4O3/c1-35-23-12-17(9-10-29-23)16-5-7-21(8-6-16)32-14-20(15-32)31-22(33)13-30-24(34)18-3-2-4-19(11-18)25(26,27)28/h2-4,9-12,16,20-21H,5-8,13-15H2,1H3,(H,30,34)(H,31,33) KTQOBGHRYHVWCO-UHFFFAOYSA-N 50353218 CHEMBL1829621 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 6200 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353218 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353218&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 46944853 136359904 CHEMBL1829621 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50661018 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)C1CCC(CC1)c1c[nH]c2ccccc12 |(15.4,2.88,;14.07,3.65,;14.07,5.19,;15.4,4.43,;12.74,2.88,;12.74,1.33,;11.4,.56,;10.07,1.34,;10.09,2.87,;11.41,3.64,;8.75,3.64,;8.76,5.18,;7.42,2.88,;6.09,3.65,;4.75,2.89,;4.75,1.35,;3.42,3.66,;2.08,2.89,;1.68,1.41,;.19,1.81,;.6,3.3,;-1.15,1.05,;-1.15,-.49,;-2.47,-1.25,;-3.8,-.49,;-3.8,1.05,;-2.47,1.83,;-5.14,-1.26,;-4.97,-2.79,;-6.37,-3.43,;-7.41,-2.29,;-8.94,-2.3,;-9.71,-.98,;-8.95,.36,;-7.42,.36,;-6.64,-.96,)| InChI=1S/C27H29F3N4O2/c28-27(29,30)19-5-3-4-18(12-19)26(36)32-14-25(35)33-20-15-34(16-20)21-10-8-17(9-11-21)23-13-31-24-7-2-1-6-22(23)24/h1-7,12-13,17,20-21,31H,8-11,14-16H2,(H,32,36)(H,33,35) FJNWTDVVZNEGPW-UHFFFAOYSA-N 50353226 CHEMBL1829604 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 2400 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353226 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353226&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 46946452 136359912 CHEMBL1829604 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 8IOB,8IO5,8IO4,5VA2,8ZYQ,8ZYP,8ZYO,8ZYN,7CN1,7CN0,5VA1,9CHS,9CHR,9CHQ,9CHP,5VA3,2L4R,4HQA,2L0W,6SYG,2N7G Voltage-gated inwardly rectifying potassium channel KCNH2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Voltage-gated inwardly rectifying potassium channel KCNH2 A0A090N8Q0_HUMAN A0A090N8Q0 50661019 Oc1ccc(cc1)[C@H]1CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F |r,wU:7.7,wD:10.14,(12.86,-42.14,;14.19,-41.36,;15.53,-42.13,;16.86,-41.36,;16.85,-39.82,;15.52,-39.05,;14.18,-39.81,;18.18,-39.05,;18.18,-37.51,;19.51,-36.73,;20.84,-37.51,;20.84,-39.05,;19.51,-39.81,;22.18,-36.75,;23.67,-37.15,;24.07,-35.67,;22.58,-35.27,;25.41,-34.9,;26.74,-35.68,;26.73,-37.22,;28.07,-34.91,;29.41,-35.68,;30.74,-34.92,;30.75,-33.38,;32.07,-35.69,;32.06,-37.23,;33.39,-38,;34.73,-37.23,;34.73,-35.69,;33.39,-34.92,;36.06,-34.92,;37.39,-35.68,;36.06,-33.38,;37.39,-34.14,)| InChI=1S/C25H28F3N3O3/c26-25(27,28)19-3-1-2-18(12-19)24(34)29-13-23(33)30-20-14-31(15-20)21-8-4-16(5-9-21)17-6-10-22(32)11-7-17/h1-3,6-7,10-12,16,20-21,32H,4-5,8-9,13-15H2,(H,29,34)(H,30,33) VJYPOQFOBLLZGR-UHFFFAOYSA-N 50353211 CHEMBL1829613 C-C chemokine receptor type 2 Homo sapiens 42 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353211 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353211&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49764447 136359897 CHEMBL1829613 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2 50661020 FC(F)(F)c1cccc(c1)C(=O)NCC(=O)NC1CN(C1)[C@H]1CC[C@@H](CC1)c1ccc2nc[nH]c2c1 |r,wU:24.29,wD:21.22,(37.55,4.46,;36.21,5.23,;36.21,6.77,;37.54,6,;34.88,4.46,;34.88,2.91,;33.54,2.14,;32.21,2.91,;32.23,4.45,;33.55,5.22,;30.9,5.22,;30.9,6.76,;29.56,4.46,;28.23,5.23,;26.89,4.47,;26.89,2.93,;25.56,5.24,;24.23,4.47,;23.82,2.99,;22.34,3.39,;22.74,4.88,;21,2.63,;19.67,3.41,;18.34,2.63,;18.34,1.09,;19.67,.33,;21,1.09,;17.01,.32,;17.01,-1.21,;15.69,-1.99,;14.34,-1.22,;12.87,-1.71,;11.95,-.46,;12.86,.8,;14.34,.33,;15.67,1.09,)| InChI=1S/C26H28F3N5O2/c27-26(28,29)19-3-1-2-18(10-19)25(36)30-12-24(35)33-20-13-34(14-20)21-7-4-16(5-8-21)17-6-9-22-23(11-17)32-15-31-22/h1-3,6,9-11,15-16,20-21H,4-5,7-8,12-14H2,(H,30,36)(H,31,32)(H,33,35) VKTHBCCPYLGDJQ-UHFFFAOYSA-N 50353207 CHEMBL1829617 C-C chemokine receptor type 2 Homo sapiens 27 ChEMBL 10.1016/j.bmcl.2011.06.080 10.7270/Q2FJ2H5C 21783361 Zhang, X; Hufnagel, H; Markotan, T; Lanter, J; Cai, C; Hou, C; Singer, M; Opas, E; McKenney, S; Crysler, C; Johnson, D; Sui, Z 8/22/2011 3/24/2012 Johnson & Johnson Pharmaceutical Research and Development http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50353207 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6463&target=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50353207&enzyme=C-C+chemokine+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 49763931 136359893 CHEMBL1829617 1 MLSTSRSRFIRNTNESGEEVTTFFDYDYGAPCHKFDVKQIGAQLLPPLYSLVFIFGFVGNMLVVLILINCKKLKCLTDIYLLNLAISDLLFLITLPLWAHSAANEWVFGNAMCKLFTGLYHIGYFGGIFFIILLTIDRYLAIVHAVFALKARTVTFGVVTSVITWLVAVFASVPGIIFTKCQKEDSVYVCGPYFPRGWNNFHTIMRNILGLVLPLLIMVICYSGILKTLLRCRNEKKRHRAVRVIFTIMIVYFLFWTPYNIVILLNTFQEFFGLSNCESTSQLDQATQVTETLGMTHCCINPIIYAFVGEKFRSLFHIALGCRIAPLQKPVCGGPGVRPGKNVKVTTQGLLDGRGKGKSIGRAPEASLQDKEGA 7XA3 C-C chemokine receptor type 2 CCR2_HUMAN P41597 A0AVQ3 B2RMT0 O95950 Q4VBL2